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Histopathology serves as the gold standard in the process of cancer diagnosis and
unravelling the disease heterogeneity. In routine practice, a trained histopatholo-
gist performs visual examination of tissue glass slides under the microscope. The
objective of the visual examination is to observe the morphological appearance of
tissue sections, analyse the density of tumour rich areas, spatial arrangement, and
architecture of different types of cells. However, careful visual examination of tissue
slides is a demanding task especially when workloads are high, and the subjective
nature of the histological grading inevitably leads to inter- and even intra-observer
variability. Attaining high accuracy and objective quantification of tissue specimens
in cancer diagnosis are some of the ongoing challenges in modern histopathology.
With the recent advent of digital pathology, tissue glass slides can now be scanned
with digital slides scanners to produce whole slide images (WSIs). A WSI contains
a high-resolution pixel representation of tissue slide, stored in a pyramidal structure
and typically containing 1010 pixels. Automated algorithms are generally based on
the concepts of digital image analysis which can analyse WSIs to improve the pre-
cision and reproducibility in cancer diagnostics. The reliability of the results of an
algorithm can be objectively measured and improved against an objective standard.
In this thesis, we focus on developing automated methods for quantitative
assessment of histology WSIs with the aim of improving the precision and repro-
ducibility of cancer diagnosis. More specifically, the designed automated computa-
tional pathology algorithms are based on deep learning models in conjunction with
algebraic topology and visual attention mechanisms. To the best of our knowledge,
the applicability of attention and topology based methods have not been explored in
xi
the domain of computational pathology. In this regard, we propose an algorithm for
computing persistent homology profiles (topological features) and propose two vari-
ants for effective and reliable tumour segmentation of colorectal cancer WSIs. We
show that incorporation of deep features along with topological features improves
the overall performance for tumour segmentation.
We then present the first-ever systematic study (contest) for scoring the hu-
man epidermal growth factor receptor 2 (HER2) biomarker on breast cancer histol-
ogy WSIs. Further, we devise a reinforcement learning based attention mechanism
for HER2 scoring that sequentially identifies and analyses the diagnostically relevant
regions within a given image, mimicking the histopathologist who would not usually
analyse every part of the slide at the highest magnification. We demonstrate the
proposed model outperforms other methods participated in our systematic study,
most of them were using state-of-the-art deep convolutional networks. Finally, we
propose a multi-task learning framework for simultaneous cell detection and classifi-
cation, which we named as Hydra-Net. We then compute an image based biomarker
which we refer as digital proximity signature (DPS), to predict overall survival in
diffuse large B-cell lymphoma (DLBCL) patients. Our results suggest that patients
with high collagen-tumour proximity are likely to experience better overall survival.
xii
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Cancer is an ensemble of related diseases originating from uncontrolled proliferation
of cells and regarded as a major challenge in modern medicine [1]. In 2018, nearly
17 million new cancer cases were diagnosed and 9.5 million cancer related deaths
occurred, as reported by the International Agency for Research on Cancer (IARC)
[2]. In males, the most common types of cancer are lung, prostate, and colorectal
cancer, whereas in females breast, colorectal, and lung cancer are the most common
cancers [3]. Carcinogenesis in humans is linked with progressive genetic abnormali-
ties, which result in the transformation of normal cells to tumour cells. Generally,
the proliferation of healthy cells is intricately regulated by genes, whereas in tumour
cells, a variety of mutations lead to uncontrolled cell growth [4]. Broadly, cancer
can be categorised into benign tumour (non-invasive) and malignant tumour (able to
metastasise, invasive). In metastasis, tumour cells spread from the primary tumour
(origin) to nearby tissues, lymph nodes or organs, and initiate tumour development
in other parts of the body.
Histology and cytology serve as the backbone in the process of cancer diag-
nosis and understanding disease heterogeneity. The diagnostic process starts with
extraction of a tissue sample from a biopsy, which is generally an organ-specific
process. Some common ways of collecting the tissue sample include: needle biopsy,
endoscopy, and surgery. The next step is to preserve the gross tissue specimen by
freezing or paraffin embedding. A microtome is normally used to section the tis-
sue into thin slices, typically of 5 microns in thickness. Sectioned tissue regions
are then mounted on to glass slides, and stained with special chemical markers
to highlight different tissue structures. One of the most commonly used stains
is Haematoxylin and Eosin (H&E). Haematoxylin binds with nucleic acids (DNA,
RNA) and dyes dense nuclei as dark blue or violet, whereas Eosin dyes cytoplasmic
1
substance as pink, including proteins, nutrients and muscles (connective) tissues.
Immunohistochemical (IHC) staining is another commonly used approach, where
chemical biomarkers identify the over-expression of a specific protein. The rou-
tine IHC staining for breast cancer patients includes oestrogen and progesterone
(ER/PR) hormone receptors, Ki67 for tumour cell proliferation, and a membranous
marker for Human epidermal growth factor receptor 2 (HER2). After staining, the
sections are visually examined by an expert pathologist under the optical microscope
to determine if the specimen is malignant or benign.
1.1 Tumour Morphology and Histological Analysis
The objective of visual examination is to determine the histological grade of cancer
which is normally done by observing the morphological appearance of tissue sections,
quantifying the density of tumour rich areas, analysing spatial arrangement and
structure of tumour cells [5]. Histological grading varies for different types of cancer,
but generally, tumours are graded into 3 categories low-grade, moderate, and high-
grade tumours [6]. Grading information is later used for selecting treatment options
and predictive analysis.
In this section, we provide an overview to the histology of different cancer
types presented in this thesis.
1.1.1 Colorectal Cancer
Colorectal cancer (CRC), also known as colon or bowel cancer, originates in the
colon or the rectum, and occurs due to the abnormal growth pattern of cells. CRC
is the third most commonly diagnosed cancer in males and the second most in
females [7], with an estimated 1.4 million cases and 693,000 deaths occurring in
2012 [8]. According to the National Cancer Institute (NCI), around 4.3% of the
human population will be diagnosed with CRC during their lifetime, based on 2012-
2014 data1. CRC results from excessive growth of malignant (cancer) cells in the
colon or the rectum. The most common form of CRC is adenocarcinoma (found in
up to 95% of CRC cases) which develops in epithelial glandular cells — these are
the glands that secrete mucus, which lubricates the colorectal region.
In routine diagnostic process of CRC, the pathologist analyses tissue sec-
tions on glass slides under the microscope to observe morphological features and
the variability of nuclear morphology. The morphology of epithelial glandular cells
is one of the most important features used in clinical practice for the grading of
1https://seer.cancer.gov/statfacts/html/colorect.html
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Figure 1.1: Visual fields showing different histology grades for colorectal adenocar-
cinoma cancer. (a) Well differentiated, (b) moderately differentiated, and (c) poorly
differentiated.
3
colorectal adenocarcinoma (CAC) [9]. CAC tumours can be broadly categorised as
low grade or high grade. A low-grade tumour refers to glandular cancer cells with
a well-differentiated morphological appearance and tumour, with cancer cells that
are poorly differentiated, or undifferentiated are known as a high-grade tumour. In
addition to low and high-grade tumours, there also exists moderately differentiated
tumour regions. Generally, the histological grading for CAC is estimated by subjec-
tive assessment of glandular formation [10]. CAC tissue slides with 95% of glandular
structures are categorised as well differentiated tumours. A grade of moderately dif-
ferentiated is assigned to cases where glandular structures lie between 50% and 95%.
Poorly differentiated and undifferentiated grades are those where the glandular for-
mulation lies within 5-50% and < 5%, respectively. Figure 1.1 shows the visual fields
of CAC with different histological grades. As tumour transforms from low to high
grade, tumour epithelial cells exhibit atypical characteristic. For example, nuclei
become relatively large, with heterogeneous chromatin texture and irregularities in
their shape and size. Due to uncontrolled cell division, for moderately and poorly
differentiated grades, the structure of individual glands is difficult to discern. Prior
to cancer grading or quantitative analysis, identification of tumour-rich areas is con-
sidered to be one of the primary tasks for a pathologist and for a computer-aided
diagnosis system.
1.1.2 Breast Cancer
Breast cancer (BC) is the most commonly diagnosed cancer among women and the
second leading cause of cancer related deaths worldwide [11]. According to Can-
cer Research UK, the risk for women being diagnosed with BC is one in eight in
the United Kingdom, and approximately 11,600 women died from BC in 2012 [12].
Broadly, BC can be categorised into two groups, based on tumour origin and mor-
phology: ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC).
DCIS is a non-invasive carcinoma and the most common form of BC (found in up
to 80% of diagnosed BC cases [13]) where the growth of malignant cells is confined
only to breast ducts. IDC is an advanced stage of invasive carcinoma, where malig-
nant epithelial cells infiltrate through the ductal wall and invade into the regions of
the nearby tissue. The Nottingham Histologic Grading system is the most widely
accepted histologic grading system [14], which classifies tumour into 3 grades based
on the morphological appearance of malignant epithelial cells.
In routine diagnostic practice of BC, tumour tissue sections are stained with
H&E and then examined under the optical microscope for morphological assess-
ment and grading. In addition, tissues are stained with IHC to evaluate biomarker
4
Figure 1.2: Examples of commonly used immunohistochemical stained visual fields
with negative (first column) and positive (second column) response.
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expression for prognostic and predictive purposes. The most commonly used IHC
stains are HER2, ER, PR, Ki67, and p53, as shown in Figure 1.2 with positive and
negative visual fields. More specifically ER, PR and HER2 are considered as an
integral part for routine BC diagnosis. As opposed to other commonly used IHC
stains, HER2 is a membranous stain (as shown in Figure 1.3) and the over ampli-
fication of HER2 is estimated by the percentage of cells with complete membrane
staining. HER2 mainly influences the growth of malignant epithelial cells located
in invasive tumour regions. In HER2+ (positive) patients, tumour cells experience
uncontrolled growth as compared to HER2- (negative) cases. Invasive breast car-
cinomas cases are recommended for HER2 testing and the overexpression of HER2
protein is identified in nearly 20-30% of cases[15]. Recent studies have reported the
HER2 status as a predictive and prognostic factor which is associated with poor
prognosis, lower survival, and high recurrence [16]. Precise quantification of HER2
overexpression is also crucial for ensuring that HER2+ patients receive appropriate
anti-HER2 hormonal therapies [17].
1.1.3 Diffuse Large B-cell Lymphoma
Lymphomas are malignancies derived from lymphocytes (a type of white blood
cell) and are broadly categorised into B-cell and T-cell lymphomas, reflecting the
origin of the respected cell. B-cell malignancies are further categorised into low
grade and high-grade lymphomas. More specifically, diffuse large B-cell lymphoma
(DLBCL) is an aggressive (rapidly-growing) malignancy, affecting the growth of B-
type lymphocytes that are responsible for antibody production. DLBCL is the most
common high-grade lymphoma in Western populations [18], affecting individuals
with a median age of 70 years at the time of diagnosis [19].
Routine pathological assessment is performed by a hematopathologist who
examines the tissue samples under the microscope dissected from the affected lymph
nodes. The objective of the visual examination is to assess the nodal architecture
and categorise tissue samples in four stages as recommended by the Ann Arbor
classification system [20] (Table 1.1). Patients with stage I or II are considered to
have an early stage DLBCL and are normally treated with either complete or a
brief course of chemotherapy. DLBCL patients with stage III or IV are considered
to have an advanced stage disease. The most common route for the treatment of
high-stage DLBCL is a combination of chemotherapy and monoclonal rituximab.
The introduction of modern chemotherapeutic regimens which include ritux-
imab has led to improved survival for DLBCL patients [21]. Despite these advances,
approximately 40% of patients will not show a lasting response to therapy and
6
Figure 1.3: Example of two visual fields (left) H&E stain and (right) HER2 stain.
Table 1.1: Ann Arbor staging of diffuse large B-cell lymphoma [20]
Stage Staging description
I A single organ or site contains tumour (around a single lymph node)
II
At least two organs or sites in lymphatic regions of same side of
diaphragm contain tumour
III
Lymphatic regions (including organs and lymph nodes) contain
tumour on both side of the diaphragm
IV
Diffuse or disseminated association of one of multiple extralymphatic
organs (like liver, lung nodules, bone marrow)
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Figure 1.4: Example of three visual fields showing the proximity of collagen and
tumour/normal cells with varying quantity of collagen fibre. (a) red triangle shows
the abundance of collagen (b) chicken wire structure of collagen and (c) sparse
representation of collagen. 8
will inevitably die of their disease [22]. This variability in treatment response in
part reflects the biological heterogeneity of the disease. In recent years, significant
progress has been made in unravelling this heterogeneity. Elucidation of the effects
of cell-of-origin gene expression profile and most recently exome and transcriptome
sequencing, have identified biological and clinically distinct subgroups of the dis-
ease [23, 24]. This has led to better prognostic stratification in routine clinical
practice and offers the potential for better-targeted therapies in the coming years.
Recent studies have also begun to investigate the role of the tumour and stromal
microenvironment in DLBCL [25, 26]. An important component of the acellular
stromal microenvironment is collagen (as shown in Figure 1.4) and previous stud-
ies have linked the presence of collagen with patient outcome [27], and staging of
tumours [28].
1.2 Digital Pathology
Visual examination of tissue mounted on glass slides under the microscope to analyse
the morphological features is the gold standard for cancer diagnosis [29]. However,
careful visual examination of tissue slides is difficult when workloads are high, and
the subjective nature of the task inevitably leads to inter- and even intra-observer
variability in some areas of diagnosis and disease classification [30, 31]. Objective
quantification of tissue specimens and attaining high accuracy in cancer diagnosis
are some of the ongoing challenges in tissue histology [32, 33]. One of the obvious
reasons is the subjective nature of cancer grading and tissue slide preparation. Pre-
viously, several modifications have been suggested to overcome subjectivity while
grading tumours. The Bloom-Richardson grading system [14] and revised HER2
guidelines and recommendations [34] are two such examples. To some extent, these
recommendations have served to improve standards in cancer grading but by and
large, these recommendations lack quantitative precision and may still lead to inter-
and intra-observer variability. In contrast, automated algorithms can analyse the
data with reproducible results. The reliability of the results of an algorithm can be
objectively measured (for example against a patient’s subsequent clinical progress)
and then improved against an objective standard. This is now possible with the ad-
vent of digital slides scanners, as hundreds of glass tissue slides can now be scanned
in a single run of the scanner.
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Figure 1.5: An illustration of a whole-slide image and the pyramidal structure con-
taining different magnifications.
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Figure 1.6: Example showing image as matrix of red, green, and blue channels.
1.2.1 Whole Slide Images
A whole-slide image (WSI) is a multi-resolution gigapixel image typically stored in
a pyramid structure, formed by scanning a conventional glass slide at microscopic
resolution. A WSI contains a detailed pixel level representation of tissue slide and
typically contain 1010 pixels. The pyramid structure consists of multiple magnifica-
tion levels, generally ranging between 40× (with scan resolution of approximately
0.25µm/pixel) to lower than 0.625×, see Figure 1.5. On average, an uncompressed
version of a WSI at 40× requires approximately 56 GB [35] of memory. Loading an
entire WSI into GPU or CPU memory is a non-trivial and computationally demand-
ing task. Therefore, WSIs are stored in different file formats equipped with lossless
compression including tiles produced by Aperio (.svs), Hamamatsu (.ndpi), Leica
(.scn), MIRAX (.mrxs), Omnyx (.jp2), and Philips (.tiff) scanners. Reading and re-
trieving data from these WSI formats requires custom libraries, like OpenSlide [36]
(written in C) or Kakadu [37] (C++).
Overall, this paradigm shift towards slide scanning has not only revolu-
tionised the process of cancer diagnosis by replacing the optical microscope with
WSIs, but it has also paved the way for computer-assisted diagnosis. Some other
potential advantages are the development of telepathology workstations which may
assist in remote diagnosis and telepathology training. With the adoption of slide
scanners and the increasing number of cancer cases, it is imperative to develop
computational pathology algorithms that can assist the histopathologists in their
diagnosis of cancer.
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1.2.2 Computational Pathology Algorithms
Computational pathology refers to a discipline that utilises varied forms of relevant
data (including imaging and clinical data) to design computational models that
analyse the data and presents clinically relevant knowledge to experts for improving
histology based diagnosis and patient treatment [38]. Due to the nature of the data
(images) used in digital pathology, the computational models are typically built on
the concepts of digital image analysis and computer vision. More specifically, these
models learn morphological and textural characteristics either using hand-crafted
(shallow learning) or data-driven (deep learning) approaches. We have leveraged
some of these approaches within this thesis for automatic WSI analysis, with the
aim to improve the precision and reproducibility of cancer diagnosis.
While the adoption of slide scanners has greatly advanced the progress in
computational pathology, it has also inherited some of the challenges faced by the
domains of computer vision and image processing. The fundamental disparity is how
human and machines perceive the provided information. Machines are designed to
understand data in the form of numbers (binary, octal, hexadecimal, etc.) and
similarly, each image is presented in the form of matrices, as shown in Figure 1.6.
Whereas we as humans inherit knowledge to process visual information. Therefore,
varying standards in histology images may result in producing low quality images
which may adversely affect the performance of the underlying model (two such
examples are shown in Figure 1.7).
There is a wealth of information available in each cancerous WSI containing
thousands of nuclei with varying levels of heterogeneity. Processing, analysing, and
retrieving meaningful outcome from these large scale images is a computationally
intensive task. Therefore, automated algorithms are generally structured into a se-
quence of algorithms. The pipeline of automated workflow is crucial for efficient
training, inference, and deployment of frameworks. The most common approach
for automated analysis of WSIs involves a pre-processing step comprising of tissue
segmentation and tiling tissue regions into small patches for training the underly-
ing model. The pre-processing step is generally followed by training a patch-based
supervised, unsupervised, or reinforcement model to learn relevant information and
predict the outcome of each input patch. The work presented in this thesis utilises
deep learning models in conjunction with algebraic topology and visual attention
mechanisms. Persistent homology is an algebraic tool for studying topological fea-
tures using the structure of a given space. Generally, persistent homology is com-
puted using simplicial homology by forming n-dimensional simplices. For analysing
images, we can avoid the use of simplicial homology by forming filtration space that
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essentially means a growing sequence of subspaces. For a given visual scenario, we
(humans) can effectively localise potential regions of interest to understand the over-
all scenario. Similarly, the concept of visual attention is generally used in computer
vision to localise potential regions of interest, for a better understanding of a given
image. Both these concepts are further explained in relevant sections of this thesis.
The last step, in general, involves aggregation of patch-based results to the WSI
level which is typically done by aggregating the statistics from the output probabil-
ity map of each WSI. Depending on the availability of clinical data, morphological
features are further explored for potential link with clinical outcomes and survival
to facilitate better prognostication and treatment of cancer patients.
1.3 Aims and Objectives
This thesis aims to develop automated algorithms for quantitative assessment of his-
tology images. More specifically, we investigate the significance of algebraic topology
and visual attention based models to improve the robustness and accuracy in histol-
ogy image analysis. Applicability of both these concepts (attention and topology)
has not been fully explored in the domain of computational pathology. Algorithms
in the area of deep learning, computer vision, and image processing approaches
will serve as the main tools for achieving the aims of this thesis. In line with the
aforementioned aims, the following contributions have been made:
1.3.1 Main Contributions
• We derive an algorithm for computing persistent homology profiles (topological
features) which effectively transform an input patch into two 1-D statistical
distributions. These distributions capture the degree of nuclear connectivity
in a given patch of a WSI. The proposed efficient computation of persistent
homology provides an alternative to simplicial homology for 2D images.
• We propose two approaches for tumour segmentation based on the homology
profiles. One that relies on the selection of exemplar patches using convolu-
tion neural network (CNN) and patch-level classification using a variant of
k-nearest neighbours (k-NN). The second approach relies on the best of both
worlds by ensembling persistent homology profiles with deep convolutional
features.
• We report on the first-ever systematic study (contest) for scoring the over-
expression of HER2 biomarker on BC histology WSIs that has instigated a
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Figure 1.7: Examples showing different types of artefacts in histological images:
(top) an over-stained histology samples and (bottom) tissue folding.
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dedicated platform for researchers to contribute and assess the performance
of their automated algorithms.
• We devise a reinforcement learning based attention mechanism that sequen-
tially identifies and analyses the diagnostically relevant regions within a given
image. To inhibit the model to reiterate previously selected regions, we pro-
pose an inhibition of return (IoR) strategy, giving higher priority to regions
that have not previously considered for learning.
• We propose an image based biomarker, which we refer to as Digital Prox-
imity Signature (DPS), to predict the overall survival in DLBCL patients.
For tumour cell detection and classification, we propose a multi-task learning
framework, which is named Hydra-Net.
1.4 Thesis Organisation
Chapter 2. Persistent Homology for Fast and Accurate Tumour Seg-
mentation. This chapter presents a tumour segmentation framework based on the
concept of persistent homology profiles (PHPs) and deep learning. Persistent homol-
ogy is an algebraic tool from homology theory that computes topological features
of a given filtration space. The PHPs are devised to distinguish tumour regions
from their normal counterparts by modelling the atypical characteristics of tumour
nuclei. The framework contains two variants of our method: one that targets speed
without compromising accuracy and the other that targets higher accuracy. The fast
version is based on a selection of exemplar image patches from a CNN and patch
classification by quantifying the divergence between the PHPs of exemplars and the
input image patch. Comparative evaluation shows that the proposed algorithm is
significantly faster than competing algorithms while achieving comparable results.
The accurate version combines the PHPs and high-level CNN features and employs
a multi-stage ensemble strategy for image patch labelling. Experimental results
demonstrate that the combination of PHPs and CNN features outperforms compet-
ing algorithms. This study is performed on two independently collected colorectal
datasets containing adenoma, adenocarcinoma, signet and healthy cases. Collec-
tively, the accurate tumour segmentation produces the highest average patch-level
F1-score, as compared with competing algorithms, on malignant and healthy cases
from both the datasets.
Chapter 3. A Systematic Study on IHC HER2 Scoring Algorithms. Es-
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timating over-amplification of HER2 on invasive BC is regarded as a significant
predictive and prognostic marker. This chapter reports on a systematic study based
on an automated HER2 scoring contest, held in conjunction with the Pathologi-
cal Society of Great Britain & Ireland (PathSoc) meeting held in Nottingham in
June 2016, aimed at systematically comparing and advancing the state-of-the-art
automated methods for HER2 scoring. The contest dataset comprised of WSIs of
sections from 86 cases of invasive breast carcinoma stained with both H&E and IHC
for HER2. The ground-truth (GT) for the contest was collected by a consensus
score from at least two experts. It also contains a simple Man vs Machine contest
for the scoring of HER2 and shows that the automated methods could outperform
the pathology experts on this contest dataset.
Chapter 4. Learning where to see: Attention Model for Automated IHC
Scoring. This chapter presents a novel deep reinforcement learning (DRL) based
model that treats IHC scoring of HER2 as a sequential learning task. For a given
image tile sampled from multi-resolution giga-pixel WSI, the model learns to se-
quentially identify some of the diagnostically relevant regions of interest (ROIs) by
following a parameterised policy. The selected ROIs are processed by recurrent
and residual convolution networks to learn the discriminative features for differ-
ent HER2 scores and predict the next location, without requiring to process all
the sub-image patches of a given tile for predicting the HER2 score, mimicking the
histopathologist who would not usually analyse every part of the slide at the highest
magnification. The proposed model incorporates a task-specific regularisation term
and inhibition of return mechanism to prevent the model from revisiting the previ-
ously attended locations. We evaluated our model on a publicly available dataset
from the HER2 scoring challenge contest. We demonstrate that the proposed model
outperforms other methods based on state-of-the-art deep convolutional networks.
The proposed algorithm could potentially lead to wider use of DRL in the domain
of computational pathology reducing the computational burden of the analysis of
large multi-gigapixel histology images.
Chapter 5. Tumour-Collagen Proximity Analytics. This chapter presents an
automated method to investigate the spatial proximity of collagen (type VI) and tu-
mour cells in DLBCL cases. For each WSI, we calculate the DPS, which represents
summary-level statistics of tumour-collagen proximity. The core components of the
proposed framework involve: a) cell detection and classification, (b) finding the ref-
erence points from the collagen fibres, and c) calculation of DPS. To the best of our
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knowledge, this is the first study that performs automated analysis of tumour and
collagen on DLBCL to identify potential prognostic factors. Experimental results
favour our cell classification algorithm over conventional approaches. In addition,
our results show that strongly associated tumour-collagen regions are statistically
significant in predicting overall survival (OS) in DLBCL patients.
Chapter 6. Conclusions and Future Work This chapter summarises the main




Persistent Homology for Fast
and Accurate Tumour
Segmentation
Localisation of malignant tumour regions in H&E stained slides is an important first
task for a pathologist while diagnosing CRC. Manual segmentation of tumour regions
from glass slides is a challenging and time consuming task. Therefore, automated
localisation of tumour-rich areas is a vital step towards a computer-assisted diagnosis
and quantitative image analysis. Accurate segmentation of tumour-rich areas may
also assist pathologists in understanding disease aggressiveness and selection of high
power fields for tumour proliferation grading and scoring. In a recent study [39],
it has been shown that precise localisation of tumour epithelial regions in CRC
can overcome the association of non-malignant stroma regions in gene expression
profiling, which also provides substantial prognostic information for individual cases.
Hence, automated tumour segmentation of CRC tissue slides could potentially speed
up the diagnostic process and overcome the inter-observer variability of conventional
methods [40, 41].
Tumour regions can be distinguished from normal regions using the appear-
ance of cell nuclei [42, 43]. In tumour regions, epithelial nuclei have atypical char-
acteristics — relatively large nuclei, with heterogeneous chromatin texture and ir-
regularities in their shape and size. Due to uncontrolled cell division, tumour nuclei
sometimes form clusters filling inter-cellular regions, as shown in Figure 2.1. In
some cases with moderately and poorly differentiated grades, the structure of in-
dividual nuclei is difficult to discern. In contrast, nuclei retain their structure and
morphological appearance in normal regions including stroma, lymphocytes, normal
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mucosa, and adipose tissue regions.
We show that important morphological differences between normal and can-
cer nuclei can be measured using persistent homology, a mathematical tool explained
in Section 2.2. We propose two persistent homology based methods for tumour seg-
mentation of H&E stained WSIs including a) homology based fast and reliable
tumour segmentation b) accurate tumour segmentation by combining the homolog-
ical and deep convolutional features to enhance the classification accuracy of a deep
CNN. We validate the proposed methods with relatively large datasets containing
both malignant and healthy cases from two independent institutions. Generally, in
a clinical setup, a WSI scanner processes 500 to 1000 glass slides each day and so
analysing data from a single scanner may require the processing of several terabytes
of new data each day. We, therefore, make a particular point in quoting run times,
and show that our fast and reliable tumour segmentation algorithm is significantly
faster than a conventional CNN and other competing approaches.
2.1 Related Work
Existing literature on tumour segmentation in histology images can be broadly clas-
sified into two categories: 1) hand-crafted feature learning methods and 2) data-
driven deep feature based algorithms. In this section, we review previous work
regarding the tumour segmentation on images of H&E stained slides. Literature
review on other related methods is covered in relevant sections, where appropriate.
A wide range of studies have been published on the use of texture, mor-
phological and colour features for tumour segmentation. Perception-based features
[44], local binary patterns (LBP) along with contrast measure features [45], colour
graphs [46], Gabor and histogram features [47, 48],and bags-of-superpixels pyramid
[49], have been used to segment tumour rich areas. Weakly supervised multiple
clustered instance approaches [50, 51] have also been proposed for segmentation of
tumour in tissue micro arrays (TMAs) of colon cancer images, by which bags of
selected patches are generated to learn the model in a multiple instance framework.
The multiple clustered instance model learns from a set of general features like the
L*a*b colour histogram, LBP, multiwavelet transforms, and scale invariant feature
transforms. However, the selection of an optimal set of features for fully or weakly
supervised learning is an onerous task and poses the risk of over-emphasising some
particular features of a dataset. Moreover, a major shortcoming of the above algo-
rithms is the fact that their scope is mainly limited to hand-picked visual fields or
TMAs. In a clinical setup, a tumour segmentation solution should be capable of
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Figure 2.1: An example of a whole slide image with 6 regions-of-interest (ROIs) to
illustrate the degree of connectivity between nuclei in tumour and normal regions.
The zoomed-in regions are of size 140.8 × 140.8 µm2, which is equivalent to 20×
magnification. ROIs with green rectangles (with label N) shows non-tumour whereas
sub-region with red rectangles (with label T) shows tumour areas.
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scaling the results to the WSI level.
Deep learning has recently produced exceptional performance on tasks in
computer vision [52] and in medical image processing [32, 53, 54]. One of the
well-known methods for segmentation is to learn a set of hierarchical features by
employing a combination of down and up sampling convolution layers, such as U-net
[55]. These approaches perform reasonably well for pixel level segmentation but are
computationally expensive and may encounter the vanishing gradients problem while
training. Cruz-Roa, et al. [56] presented a CNN framework for tumour detection in
breast histology images. Our CNN architecture for tumour segmentation has some
basic similarities with the proposed framework in [56]. However, our CNN model
is relatively deep, enabling the model to learn a set of features at various levels of
abstraction. In a supervised learning environment, one can think of deep learning
features as a set of data-driven features, learnt by using back propagation (BP).
The BP algorithm penalises the kernel maps by forcing them to learn from their
mistakes on the training dataset. Instead of relying on a set of handcrafted features,
deep learning models learn the set of optimal features without human intervention.
Each of the several physical processes involved in creating a WSI, starting
with the original biopsy or resection and ending with laying a 5µm thick section
on a glass slide, is random with respect to orientation. Therefore the textural and
geometric features in a WSI will have a random orientation, though the orientations
of different features may well be correlated with each other. However, deep learn-
ing models and especially CNNs find difficulty in learning the rotationally invariant
characteristics of an input image [57]. In contrast, our biologically interpretable
PHPs not only capture the degree of connectedness among nuclei but are also in-
variant to rotational transformations.
2.2 Persistent Homology
Persistent homology is an algebraic tool, whereby, given a topological space, certain
algebraic invariants are computed using the structure of that space. It is a fairly
recent concept of homology theory, with a wide range of applications in different
domains of data analytics including protein structure [58, 59], robotics [60, 61], neu-
roscience [62], shape modelling [63], analysing brain arteries [64], classification of
endoscopy images [65], mutational profile and survival analysis [66], video surveil-
lance [67], time series modelling [68] and natural language processing [69]. The
concept of persistent homology is relatively new for medical image analysis in gen-
eral and for histology image analysis in particular.
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Persistent Homology theory is the study of the homology of a filtered space,
by which we mean a sequence
{∅ = X0 ⊆ X1 ⊆ X2 ⊆ · · · ⊆ Xk = X} (2.1)
This is referred to as a filtration of the topological space X. Readers are referred to
[70, 71, 72] for a description of the general theory.
In our case, we are analysing 2D greyscale images, and each Xi is the union
of closed pixels in a single image. Xk = X is the entire image. These subspaces are
so special, and with such nice properties, that dramatic simplifications are possible
in computing the persistent homology. The only homology groups that are non-zero
are in dimensions 0 and 1. We have no need to consider what is often a significant
aspect of persistent homology, namely the birth and death of homology classes. It is
sufficient for our purposes to consider only the Betti numbers β0(Xi) and β1(Xi) for
1 ≤ i < k. Betti numbers are represented by non-negative integers for discriminating
topological spaces based on their connectivity. Moreover, these Betti numbers can
be computed using basic topological ideas, namely a count of connected components,
which is a simple and rapid computational procedure. In other words, β0 represents
the number of connected components in the foreground and similarly, β1 means
counting background connected components without holes.
To explain how we generate the filtration of a given greyscale image, we sup-
pose for definiteness that the intensity of each pixel is an integer in the range [0, 255].
We then select a sequence of integers 0 = t0 < t1 < · · · < tk−1 < tk = 256. These
integers are various threshold levels, at which the image is binarised. We define Xi
to be the union of closed pixels p, with intensity I(p) < ti, so that X0 = ∅; and
Xk = X. Each greyscale image gives rise to a single filtration. A careful choice
1
of t1, t2, . . . , tk−1 balances density in [0, 255] to give all (or nearly all) the informa-
tion needed from the original greyscale image. We compute two relevant homology
groups H0(Xi) and H1(Xi) for 1 ≤ i < k as follows. Instead of using computa-
tionally expensive constructs of simplicial topology, as is normal in the literature
using persistent homology [73, 74], we compute H0(Xi) by counting the connected
components of Xi, giving the Betti number β0(Xi) and H1(Xi) by counting the
components of X \ Xi, giving the Betti number β1(Xi). For our purposes, it is
therefore sufficient to calculate, for each i with 1 ≤ i < k, these two numbers, giving
a total of 2k − 2 length of feature vector.
1We empirically decided on choosing every third possible value in the range 1..255, giving 84
levels instead of 255.
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Figure 2.2: An illustration of the filtered space associated to an image. We first
show an input image at 40× magnification, and then four images showing growing
sequence of subspaces, obtained by thresholding at increasing values of threshold.
β0 represents the number of connected components and, similarly, β1 shows the
number of one-dimensional voids (red arrows only show few of them).
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A given small patch as in Figure 2.2 represents a filtered space extracted
from a WSI. For a range of t it gives a list of subspaces such that all pixels
of previous subspace Xi−1 are present in Xi. To construct PHPs we recorded
the rank of homology groups (H0(Xi), H1(Xi)) for an entire range of t, such as
0 < t1 < t2 < · · · < tk−1 < tk = 256. We trade a considerable improvement in
speed of computation for a negligible loss in information. The algorithm for com-
puting PHPs is the main foundation for fast tumour segmentation. In this case, the
algebraic invariants turn out to be nothing more complicated than whole numbers
(ranks of homology groups, which are 0th and 1st Betti numbers). Hence we do not
need to build computationally expensive simplical complexes in order to compute
persistent features. This provides an alternative approach to simplicial homology
for 2D images.
We now present two proposed approaches based on PHPs. We first describe
the workflow of the fast tumour segmentation and then explain the algorithm for ac-
curate tumour segmentation. For a given WSI, we divide it into patches of 256×256
at 20× magnification. The problem then reduces to classification of each patch as
either tumour or non-tumour.
2.3 Fast Tumour Segmentation
The algorithm for fast tumour segmentation is established on three pivotal steps:
1) an efficient way of computing PHPs, 2) selection of representative images from
the activation maps of a convolutional network, and 3) an algorithm for patch
classification.
2.3.1 Persistent Homology Profiles
As mentioned earlier, tumour nuclei carry atypical characteristics and exhibit chro-
matin texture allowing us to distinguish them from non-tumour nuclei. Here, we
characterise these phenomena with the help of persistent homology for tumour re-
gions in CRC histology images. Our topological features provide a global description
of image patch I by finding the relationships among data points (pixels), contrary
to textural and geometrical features where precise distances, angles and spatial ar-
rangement are important. For a given patch I, we derive two statistical distributions
by computing the ranks of their 0th and 1st dimensional homology groups, denoted
by β0 and β1. We refer to these statistical distributions as persistent homology
profiles.
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Highly variable colour of histology specimens is mainly due to non standard-
isation in staining protocols. To overcome this problem we first perform stain de-
convolution [75] separating an RGB image patch into three channels, Haematoxylin,
Eosin, and background. Generally, eosin channel contains information regarding cy-
toplasmic regions, including muscles and connective tissues whereas haematoxylin
stain binds with nucleic acids and dyes dense nuclei as dark blue. Therefore, for
follow up analysis, we only use the Haematoxylin channel to improve consistency in
intensity appearances. To extract the topological features, we binarise the Haema-
toxylin channel to record the corresponding Betti numbers (β0, β1). In our case, the
topological features were only recorded for one third of possible threshold values - see
Footnote 1. These limited threshold values retain the discriminative characteristics
of PHPs by using three times fewer parameters as compared to using all threshold
values [76]. For each t, the Betti numbers are computed by counting the connected
components and one-dimensional voids. Rather than relying on hand-picked thresh-
old values, we observe the topological features at 0 = t0 < t1 < · · · < tk−1 < 256.
Later, we convert each statistical curve into a discrete probability distribution, scal-
ing the values so that the area under each curve is one.
Differences between tumour and non-tumour regions are reflected in their
homology invariants. This can be seen in Figures 2.3 and 2.4, which show the
curves representing median of our PHPs for selected exemplar patches from a CNN
(explained in Section 2.3.2 ) for both tumour and normal classes, with first (Q1)
and third (Q3) quartile. The green dotted line shows the PHPs (β0, β1) for image
patches as shown in the first column. It is worth mentioning here the magnitude of
derived PHPs is less relevant instead, the pivotal aspect is the noticeable trend in
growth of homology classes. As we start increasing the threshold t from the lower
limit (t0) to upper limit (tk−1), the filtering subspace propagates from an empty set
to the entire topological space. Since tumour regions carry more irregularities in
terms of their shape, size and tumour nuclei lie relatively close to each other filling
the inter-cellular cytoplasmic space, their homology ranks (β0, β1) do not show rapid
change while merging and forming into new classes as compared to those for non-
tumour regions.
2.3.2 Selection of Exemplar Patches
To select exemplar patches for fast tumour segmentation, we first train a deep CNN
model to predict whether a patch should be labelled as tumour or non-tumour. The
CNN architecture is inspired by [52] with some modifications, as shown in Figure
2.5. The objective here is to infer a set of representative patches from the entire
25
Figure 2.3: An example of persistent homology profiles (PHP) for the selected tu-
mour patches (left): original images with ground truth (GT), (middle): PHP for
β0, (right): PHP for β1. The shaded regions in β0 and β1 show the first and third
quartile of the exemplar patches, whereas the green dotted line shows the PHP of
selected patch.
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Figure 2.4: Another example of PHP for selected non-tumour patches (left): original
images with ground truth (GT), (middle): PHP for β0, (right) PHP for β1 .
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training dataset for both tumour and non-tumour classes by exploring the learned
activation maps from the last convolution layer. We then compute the PHPs of
selected patches in order to measure the value of divergence from an input patch as
described in the next section.
Let us consider a convolution layer with its corresponding activation maps
α ∈ RW×H×Z , where Z represents the depth of activation maps of spatial dimen-
sion H×W . The activation maps from convolution layers emphasise different tissue
parts for different layers [77]. Generally, in the first layer, neurons activate for a
combination of low-level features like edges on nuclei boundaries and chromatin ma-
terial found within nucleus. The middle layers get more sense of object localisation
by learning the most discriminative regions within the tissue patch. The top convo-
lution layer neurons reflect higher level features of tissue components and have high
activations around the object within an input image. The idea here is to collapse
the 3D activation maps of the last convolution layer into a scalar value that can
be later used as an indication of the significance of each patch with respect to the
activation maps. We first define a mapping function closely related to [78] to flatten
the 3D activation maps to 2D across the Z dimension as below,
F (w, h) =
Z∑
z=1
∣∣∣αw,h(z) ∣∣∣2 , (2.2)
Here, the mapping function gives more weight to neurons with high activations. It
is worth noting that normalising the flattened 2D activation map is important for
follow-up analysis. We compute the median value of F (w, h) to find the central
tendency of the 2D activation map, that later assist in exclusion of unimportant
patches in the training dataset. Similarly, for the entire training dataset, we get an
M×1 vector by computing the median(F (w, h)) for each patch, where M represents
the number of patches.
The last step is to find a set of exemplar patches for tumour and non-tumour
classes, separately. One way of choosing the exemplar patches is to find the highly
activated patches from the M×1 matrix. The only pitfall of following such a method
is that we may end up selecting patches representing a certain type of tumour or
normal tissue. In order to avoid this scenario, we compute the interquartile range
(IQR) [79] of M × 1 matrix separately for the tumour and non-tumour classes.
Furthermore, we split the IQR of each class into Q same size bins and select the
value that lies closest to the median of corresponding bin, where Q represents the
number of exemplar patches for each class. Comparative results for the selection of
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Figure 2.5: (A) A schematic illustration of our deep convolutional neural network
(B) An overview of the proposed exemplar selection algorithm based on activation
maps of the last convolution layer.
exemplar patches is discussed in Section 2.5.2.
2.3.3 Patch Classification
For patch classification, we first transform the PHPs into discrete probability dis-
tributions. We then compute the symmetric Kullback-Leibler divergence (KLD) to
measure the distance between the PHPs of an input patch I and the PHPs of an
exemplar patch E as defined below,







where I represents the true representation of data and E represents an approxima-
tion of I. The symmetrised, non-negative KLD is defined as
dI,E = DKL(I ‖ E) +DKL(E ‖ I). (2.4)
We compute a vector of distance values to exemplar patches D(I) = (dI,T1 ,
dI,T2 , ..., dIA,TA , dI,N1 , dI,N2 , ..., dI,NB ), containing divergence values for input patch
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PHP profiles of I and all exemplar tumour T = {T1, ..., TA} and non-tumour ex-
emplar patches N = {N1, ..., NB}. We derive a similarity measure from the KLD
values computed in (2.4) and compare the total similarity scores to the k nearest









where kt, kn denotes the number of nearest tumour and non-tumour patches accord-
ing to (2.5), and k = kt + kn. In order to classify a given image patch as tumour,
the total similarity scores of its kt nearest tumour patches should be greater than
that of the kn nearest normal patches.
2.4 Accurate Tumour Segmentation
In this variant of our algorithm, we combine deep convolutional and persistent ho-
mology features. For this we trained a CNN as shown in Figure 2.5 to extract
features from the last fully connected layer. We then fed the extracted features to a
Random Forest (RF) regression model separately for the topological and deep con-
volutional features. Finally, we propose a multi-stage ensemble strategy to combine
the two RF regression models. The main objective of this method is to combine the
best of both worlds. The key contribution of the topological features is to capture
the underlying connectivity whereas CNN tends to learn the data driven features.
2.4.1 Deep Convolutional Features
The CNN architecture contains four convolutional layers followed by an activation
function and a max-pooling operation. Additionally, it contains two fully connected
layers and the softmax classification layer to predict the label of each patch as a
tumour or non-tumour. We use rectified linear unit ReLU as activation function,
which enables faster convergence and also reduces the vanishing gradient problem.
A dropout layer at the end of the second fully connected layer is placed to overcome
the overfitting problem. The CNN was trained to minimise the overall cross entropy
loss L, as given below
L(g, y) = −(y(x)log(g(x)) + (1− y(x))log(1− g(x))) (2.6)
where for input x, g represents the ground-truth label (0 for tumor and 1 for non-
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tumor) and y is the probability of the tumor predicted by the CNN. The fully
connected layers contain non-linear combinations of learned features from the con-
volution layers. We extracted CNN features for the training dataset after the last
fully connected layer just before the softmax classification layer. For each patch of
the training dataset, we obtained a feature vector of size (1× 1× 1024).
2.4.2 Ensembling Strategy
After obtaining topological and convolutional features, we concatenate both PHPs
(β0, β1) to form a combined topological feature vector. We then train the RF
regression model separately for both types of feature. We optimise the RF model
with an ensemble of 200 bagged trees, randomly selecting one third of the variables
for each decision split and setting the minimum leaf size to 5.
We combine the probability of both regression models (O1, O2) as in (2.7),
where O1 represents a regression model of topological features and similarly O2
represents a regression model of convolutional features. The multi-stage ensemble
strategy follows two alternative routes: a) averaging the outcome probabilities of O1
and O2 to predict the output label where both regression models agree b) for the
remaining few patches (≈ 1% from the test data) where the average probabilities
lies in range 0.49 − 0.51. We refer to these as critical patches and we assign the
output label for those patches by rounding the probabilities from O1(x) as in our




0, if (O1+O2)2 < 0.49.
1, else if (O1+O2)2 > 0.51.
bO1(x)e otherwise (rounding)
(2.7)
2.5 Experiments and Results
2.5.1 Dataset and Experimental Setup
The Warwick-UHCW Dataset.
This dataset consists of 75 WSIs of H&E stained colorectal adenocarcinoma tissues.
At the highest resolution, each WSI normally contains more than 1010 pixels. The
WSIs were digitally scanned at a pixel resolution of 0.275µm/pixel (40×) using an
Omnyx VL120 scanner. The ground-truth for tumour regions were hand-marked by
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an expert pathologist. For each WSI, we randomly selected 1,500 patches including
750 from non-tumour and 750 patches from tumour regions. In total, we extracted,
75,000 patches for training from 50 WSIs and 37,500 patches for testing from 25
WSIs. The collected dataset for this study is roughly 20 times more than that in
[80] and at least 2 times more than in [76]. For generating the tumour probability
map of a WSI, we first split the given WSI into patches and then applied our methods
to each patch.
The Warwick-Osaka Dataset.
This dataset contains 50 H&E stained histology WSIs of colorectal tissue. The
WSIs were scanned at a pixel resolution of 0.23µm/pixel (40×) using a Hamamatsu
NanoZoomer 2.0-HT scanner. The ground-truth for this dataset were hand-marked
by two expert pathologists and the cases were identified as belonging to 6 categories,
including 11 cases of adenoma, 14 moderately differentiated, 6 poorly differentiated,
10 well-differentiated, 8 healthy and 1 signet case. The inclusion of normal cases in
this dataset helps in evaluating the robustness of the proposed methods as discussed
in Section 2.5.2. Similarly to the Warwick-UHCW dataset, we randomly selected
1,500 patches (750 tumour, 750 non-tumour) from each WSI.
Experimental Setting.
For our proposed methodologies we split a WSI into manageable patches of 256×256
for training as well as testing. In order to counter overfitting, we performed data
augmentation by rotating (0◦, 90◦, 180◦, 270◦), flipping (horizontal or vertical axis),
and perturbing the colour distribution (hue variation) of both the training datasets
(Warwick-UHCW and Warwick-Osaka). The colour perturbation was achieved by
randomly varying the hue in the interval [0, 0.5] and saturation between 0.5 and 1.5.






where Nin and Nout represents the number of input and output neurons, respec-
tively. The selected weight initialisation approach tends to restrict the magnitude
of gradients from excessive shrinking or growing during the training process. The
network learns the weights by using the mini-batch gradient descent algorithm by
selecting a batch size of 100. During the training phase, the initial learning rate was
set to 0.0001 and an Adam optimiser was employed instead of conventional gradi-
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ent descent algorithm. In addition, a dropout layer (dropout rate 0.5) was placed
between the two fully connected layers to overcome the interdependence among
intermediate neurons and to increase the robustness of the trained network. For
the fast tumour segmentation, we separately chose 128 exemplar patches for both
tumour and non-tumour, and k = 11 for k-NN.
Evaluation.
We compute the F1-score to evaluate the performance of different approaches as a











where Tp, Fp, and Fn represents the number of true positive, false positive, and
false negative patches. For a given test dataset, the correctly identified patches
are classified as either true positives or true negative, misclassified predictions are
categorised as false positives, and false negatives.
2.5.2 Comparative Analysis
Selection of Exemplar Patches
One of the most critical parts in the fast tumour segmentation is the selection of
exemplar patches. Hence the objective of this experiment is to investigate a few op-
tions for selection of exemplar patches. The experiment is conducted on 75 colorectal
adenocarcinoma WSIs from the Warwick-UHCW dataset. The following algorithms
were selected for comparison and as an alternative to the proposed method of ex-
emplar selection. We start with a random selection of exemplar patches from the
training dataset for both tumour and non-tumour classes. We repeat this process 10
times before concluding the final results and the reported results (Table 2.1) show
the mean precision, recall and F1-score. In k-means clustering the training dataset
was partitioned into k clusters with respect to their RGB intensities. Then we se-
lected those patches that lie closest to the cluster centroids as exemplar patches, one
patch per centroid. The third algorithm for comparison is to select highly activated
patches as exemplars from a CNN as proposed in [80]. For a fair comparison, an
equal number of exemplar patches were selected for each of the above mentioned
algorithms.
Table 2.1 reports the patch based tumour segmentation results for different
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Figure 2.6: Representative tumour and non-tumour patches from the Warwick-
UHCW and the Warwick-Osaka datasets.
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Table 2.1: Comparison of various options for selecting the exemplar patches; results
on the Warwick-UHCW dataset.
Method Precision Recall F1-score Accuracy
CNN (Section 2.3.2) 0.9272 0.8513 0.8999 0.8924
CNN (highly activated) [80] 0.9112 0.8309 0.8692 0.875
k-means 0.968 0.7559 0.8489 0.865
Random selection 0.8812 0.8309 0.8553 0.8594
approaches. Overall the results are in favour of the proposed method. Figure
2.6 shows a sample of 9 representative patches for tumour and non-tumour classes
from both the datasets using the proposed method. The CNN (highly activated)
[80] seems a straightforward approach that selects only patches where its neurons
produce high activations. However, for a relatively large dataset, the exemplars may
be overemphasised by a particular atypical WSI, where we normally have thousands
of patches from a single case. Thus, this kind of approach is more suitable for a
small dataset containing a limited number of image patches from which to select
exemplars. Another downside is the inclusion of outliers as exemplars which can
easily happen due to lack of precisely marked ground-truth. This argument remains
valid for k-means and random selection approaches.
Tumour Segmentation on Adenocarcinoma Cases
In this experiment, we evaluate the performance on the Warwick-UHCW dataset
of the proposed algorithms in comparison to some recently published algorithms
for tumour segmentation. The experiment is conducted on all 75 adenocarcinoma
WSIs where we used 75,000 randomly selected patches from 50 cases for training
and the remaining 37,500 patches from 25 WSIs for testing. For a fair comparison,
we retrained the selected algorithms on our dataset except for HyMap [47], which
is an unsupervised method. For comparative analysis we selected only algorithms
that are closely related to CRC image analysis, provided that their source codes
were released with proper implementation details and comments. The features of
the selected algorithms are as follows:
• Multi-class texture analysis [48] or MCTA: This method first computes a set of
textural features on a given image patch including lower-order and higher-order
histogram statistics, local binary patterns, grey-level co-occurrence matrix,
Gabor filter, preception-like features and then fed these features into radial-
basis function (RBF) support vector machine (SVM).
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Figure 2.7: Results of accurate tumour segmentation on the whole-slide image (WSI)
level. (A)&(E) input WSIs with annotated ground-truth, (B)&(F) tumour segmen-
tation results, green region showing the predicted tumour areas, (C)&(H) zoom in
regions containing true negatives (D)&(G) showing a sample of the true positive
tumour segmented regions.
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Table 2.2: Tumour segmentation results on the Warwick-UHCW dataset.
Method Precision Recall F1-score Accuracy
Fast Tumour Segmentation (PHP) 0.9272 0.8513 0.8999 0.8924
Accurate Tumour Segmentation
(PHP+CNN)
0.9267 0.922 0.9243 0.9245
HyMap [47] 0.6851 0.8600 0.7626 0.7323
ConvNet CNN3 [56] 0.856 0.867 0.8615 0.8606
MCTA [48] 0.8701 0.8834 0.8767 0.8843
TVIA [81] 0.8224 0.8641 0.8427 0.8387
• HyMap [47]: This is an unsupervised algorithm for tumour segmentation that
classifies each pixel as hypo or hyper cellular by computing Gabor filter, tex-
ture energy and phase-gradient features followed by ensembling the projections
for each feature. Since this is an unsupervised method, we did not retrain it
for our experiments.
• ConvNet CNN3 [56]: This method poses cancer detection as a two-class prob-
lem by assigning an ‘invasive or non-invasive’ label to each patch. The frame-
work is a combination of convolutional layers followed by pooling operations
and fully connected layers. The reported results suggest the CNN3 outper-
formed the other counterparts on breast tissue so we used only CNN3 for our
experiment.
• Texture-based tumour viability image analysis [81] or TVIA: It classifies a
given patch as viable or non-viable or as ‘other tissue parts’. They computed
local binary patterns and local contrast measures at the patch level and fed the
extracted features into a SVM model. This algorithm is not directly related to
tumour segmentation. We, therefore, evaluate it only as a two-class problem,
that is, as a decision whether to classify a patch as tumour or non-tumour.
Table 2.2 reports comparative results from the experiment and Figure 2.7
shows qualitative results for the accurate tumour segmentation on the WSI level.
Our PHP+CNN based accurate tumour segmentation produces the best results in
terms of recall and F1-score, whereas the PHP based fast tumour segmentation
performs best for the precision metric. The PHP+CNN outperformed the other
competing methods by a reasonable margin. It is encouraging that incorporating
deep features along with topological features boosts the overall performance. Gen-
erally, CNN models struggle to capture the rotation or viewpoint invariance of the
learned object. To overcome this deficiency, we need to perform flipping or sev-
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Table 2.3: Tumour segmentation results on the Warwick-Osaka dataset.
Method Precision Recall F1-score Accuracy
Fast Tumour Segmentation (PHP) 0.8259 0.8019 0.8137 0.8164
Accurate Tumour Segmentation
(PHP+CNN)
0.8311 0.8235 0.8273 0.8280
HyMap [47] 0.6469 0.7228 0.6827 0.6641
ConvNet CNN3 [56] 0.6927 0.8446 0.7612 0.735
MCTA [48] 0.7050 0.7419 0.7229 0.7157
TVIA [81] 0.6993 0.7240 0.7114 0.7063
eral arbitrary rotations on our images in the form of augmentation to make our
model more generaliseable. Data augmentation overcomes the rotational invariance
to some extent but it is still a non-trivial task to produce all possible rotations while
training a CNN classifier. In contrast, PHP captures the rotational invariance by
emphasising the merging and forming of homology classes so no matter how much
a patch is rotated the PHP will remain persistent. The PHP also captures the bi-
ological phenomenon that the connectivity among tumour and non-tumour nuclei
is significantly different. As compared to CNNs, the PHP based fast tumour seg-
mentation algorithm only consults a number of exemplar patches from both classes
in predicting the outcome of a patch. In our previous work [80], we observed that
a similar approach performs marginally better than CNN. This offers a trade-off
between accuracy and efficiency with reliable outcomes.
Tumour Segmentation on Adenoma, Carcinoma and Healthy Cases
The goal of this experiment is to test the generalisation of the proposed algorithms
on another dataset that consists of different types of epithelial tumours and healthy
cases. The experiment is conducted on 50 WSIs of the Warwick-Osaka dataset. We
perform 2-fold cross-validation by selecting half of the dataset for training and the
remaining half for testing. We then perform the same experiment by switching the
training and test datasets. Similarly to the experiment with the Warwick-UHCW
dataset we perform comparative analysis on the aforementioned selected algorithms
and by retraining them on the Warwick-Osaka dataset.
Table 2.3 shows the results from 2-fold cross-validation. It can be observed
that the proposed methods for all 3 metrics produce comparable results on an in-
dependent dataset. One of the arguments for ascribing relatively low performance
by MCTA, HyMap, and TVIA is the selection of textural features, especially local
binary patterns, local contrast measures, histogram statistics, and the grey-level
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co-occurrence matrix, that are sensitive to stain variations and image blurring. An
additional cause for the poor performance of these programs is that, due to varying
staining protocols at different centres, the morphological appearance of lympho-
cytes and benign epithelial nuclei from one centre can resemble that of malignant
epithelial nuclei from another.
Results for Healthy Cases
This experiment compares the performance of different tumour segmentation al-
gorithms for healthy cases in the Warwick-Osaka dataset. This is important for
routine clinical practice as well as in cancer screening studies, which involve a large
number of normal cases. The most challenging sections are healthy epithelial and
lymphocyte regions where nuclei are densely packed and pose difficulties in identi-
fying those regions as non-tumour. We evaluate the performance of this experiment
by the specificity metric (also known as the true negative rate), that measures the
involvement of negative samples misclassified as positive. Figure 2.8 shows the
summarised results for all the healthy cases involved in this study. The specificity
analysis demonstrates the effectiveness of the proposed ensemble strategy for accu-
rate tumour segmentation, showing that a model relying on an agreement between
topological and deep features outperforms all competing approaches.
Robustness Analysis
The aim of performing this experiment is to evaluate the robustness of the proposed
tumour segmentation algorithms by training on the Warwick-UHCW dataset and
testing on the Warwick-Osaka dataset which contains cancerous and healthy cases.
One of the most challenging aspects of processing H&E WSIs is to overcome the
non-standardised parameters involved in slide preparations like tissue sectioning,
staining duration, dyes, and formalin concentration [82]. In order to become a part
of the routine diagnosis, an automated tumour segmentation algorithm should be
resilient to these data variations. With that in mind, we perform this experiment
by keeping the parameters of the algorithms fixed during the training and testing.
Table 2.4 reports the results for robustness analysis and Figure 2.9 shows
some qualitative results. The proposed methods attain the highest accuracy among
different methods, demonstrating their robustness on strongly cross-validated data.
The stain variability in both the datasets can be observed in Figure 2.6, which shows
the selected exemplars from both the datasets. Regardless of stain variations in both
the datasets, the degree of connectivity among tumour and non-tumour class is no-
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Figure 2.8: Specificity curve for tumour segmentation algorithms on healthy cases
from the Warwick-Osaka dataset. The horizontal axis shows the index of healthy
cases selected, and the vertical axis shows the specificity.
tably distinguishable and that leads to better performance of the proposed methods.
It is interesting to note that the PHP based fast tumour segmentation marginally
outperformed the PHP+CNN based accurate tumour segmentation (0.3%). This
bodes well for the potential generalisability of fast tumour segmentation. Relatively
smaller values of F1 measure for other competing algorithms can also be noticed in
Table 2.4. Excluding HyMap, an obvious indication for a considerable drop in F1-
score is due to the precision measure. On the one hand, the competing algorithms
perform well in predicting tumour patches but at the cost of a large number of false
positives. In contrast, regardless of stain variations in the two datasets, the fast
tumour segmentation algorithm maintains a balance between precision and recall.
On the whole, there is a decrease in performance accuracy for all algorithms as
compared to their performance when trained and tested on data from the same cen-
tre, although the proposed algorithm still gives almost 8-10% higher F1-score than
other competing algorithms. One potential strategy to increase the robustness of an
underlying model is to train it on datasets from a number of different centres. Even-
tually, this will reduce the chances of overfitting and enables the learnable weights
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Figure 2.9: Robustness Analysis: results for the fast tumour segmentation on se-
lected whole-slide images (WSI) from the Warwick-Osaka dataset. (A)-(C) input
WSIs, (E)-(G) predicted tumour regions, (I)-(K) results for true positives (TP),
false positive (FP), false negative (FN), and true negative (TN) regions.
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to optimise on a variety of datasets with varying contents and staining protocols.
Table 2.4: Results for robustness analysis of different tumour segmentation algo-
rithms.
Method Precision Recall F1-score Accuracy
Fast Tumour Segmentation (PHP) 0.772 0.7890 0.7804 0.778
Accurate Tumour Segmentation
(PHP+CNN)
0.7413 0.8172 0.7774 0.7661
HyMap [47] 0.6469 0.7228 0.6827 0.6641
ConvNet CNN3 [56] 0.6234 0.8167 0.7071 0.6616
MCTA [48] 0.5429 0.9586 0.6932 0.5758
TVIA [81] 0.5334 0.9747 0.6895 0.5610
Runtime Analysis
This section contains the runtime analysis of different tumour segmentation algo-
rithms. Digitised WSIs are giga-pixel images, so fast tumour segmentation algo-
rithms could play a crucial role in delivering ‘real world’ diagnostics. For all the
algorithms, runtime analysis at the test stage is performed on a static machine hav-
ing an 8-core processor with 3.1 GHz clock speed, 128 MB of memory and a GTX
1080 Ti graphical processing unit.
Table 2.5 reports the processing time for different algorithms on a patch
of size 256×256×3 at 20×. The fast tumour segmentation is less computationally
complex and an order of magnitude faster than competing algorithms, specifically
≈ 4.2 times faster than the CNN and ≈ 5.2 times faster than the accurate tumour
segmentation. The algorithm for computing the PHPs is the foundation of fast tu-
mour segmentation. The topological features (β0, β1) are computed by enumerating
the connected components for a given filtered space. Consequently, the fast tumour
segmentation algorithm is far less computationally complex than a multi-layer con-
volutional network.
2.6 Discussion and Conclusions
This study aimed at improving the diagnostic workflow by introducing a novel
automated tumour segmentation framework for colorectal cancer histology WSIs.
Experimental results conducted on fairly challenging datasets collected from two
independent pathology centres demonstrate the efficacy and generalisability of per-
sistent homology in histopathological image analysis. In this work, we present novel
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Table 2.5: Runtime analysis in milliseconds for different tumour segmentation algo-
rithms
Method Time




HyMap [47] 931 ms
ConvNet CNN3 [56] 97.1 ms
MCTA [48] 228.12 ms
TVIA [81] 109 ms
topological signatures (PHPs) that, in some respects, resemble clinicians’ approach
for identification of tumour enrich areas. It is evident from the performance that
incorporating topological features and deep convolution features can enhance the
overall performance of a CNN for the task of accurate tumour segmentation. The
proposed framework was shown to work well on colorectal epithelial tumours of
different histology grades.
Histological assessments are generally estimated visually and producing sub-
jective measures for quantification of morphological features [83]. Computer-assisted
image analysis requires precise annotations at high resolution to effectively train an
underlying model. The inevitable fact is that the domain experts are generally not
available for this laborious task of providing precise ground-truth at high resolu-
tions. In such circumstances, the performance of a trained model may be affected
by expert annotation that is carried out too rapidly or without close attention to
detail, or by inexpert annotation. After careful consideration, we decided that this
could be a relevant factor in both datasets, resulting in a difference in performance
of the tumour segmentation algorithms (Table 2.2 & 2.3), regardless of stain and
morphological variability. Nearly all the tumour segmentation algorithms experi-
ence difficulties in some of the benign epithelial and dense lymphocytic regions,
especially where the intra-cellular region displays morphology that is similar to the
cancer-distorted nucleoplasm. In this work, we captured important morphological
differences between normal and cancer nuclei using persistent homology. However,
these morphological differences may also be explored using level-set method [84, 85].
WSI scanners are becoming more viable for routine analysis [86], capable
of producing hundreds of terabytes of data daily [35, 87]. The proposed framework
offers a decent trade-off between speed and accuracy. With this change of paradigm,
the fast tumour segmentation has enormous potential to overcome this ongoing chal-
lenge, reducing subjectivity and the pathologists’ workload. It can be observed from
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the experimental results that careful selection of the exemplar patches can nearly
obviate the need for retraining of our algorithm on a new dataset as shown in Table
2.4. One limitation of this work is that parameters like the number of exemplar
patches and k (as in k-means) are empirically selected for this study and may need
proper fine tuning, depending upon the data. The selection of a representative subset
from a dataset is an active area of research and has several applications in computer
vision and natural language processing. The proposed method for selection of ex-
emplar patches is presented as an application to deep convolution networks. In the
literature, there exist dissimilarity based subset selection methods [88, 89], but the
selection of a dissimilarity measure is a non-trivial task and computing a dissimilar-
ity matrix for a large dataset is computationally expensive. Other approaches like
loopy belief propagation [90] can handle a large dataset but do not offer any guar-
antee of convergence. In contrast, the proposed fast tumour segmentation method
exploits the learned activation maps to deduce the representative patches and is less
computationally expensive and more robust to outliers. It is also evident from the
experimental results that the accurate tumour segmentation algorithm presents a
simple yet meaningful way of combining our novel topological signatures with deep
convolution features.
In conclusion, we presented an automated tumour segmentation framework
for colorectal cancer histology WSIs based on persistent homology and deep learn-
ing. The proposed framework is validated on two independent datasets, consisting
of both malignant cases and healthy cases. Extensive comparative analysis demon-
strated better than the state-of-the-art performance of the proposed algorithms.
This study provides an insight into the topological persistence of an image and may
constitute the first step towards interpretable incorporation of homology features
in the domain of histopathology image analysis. The proposed homology profiles
and the intrinsic phenomena of cell connectivity may be applicable to other similar
problems in computational pathology.
Often after identification of tumour in a patient, pathologist needs further
information regarding the overexpression of specific proteins. The quantification of
antibodies carries huge clinical significance as it may help in planning appropriate
treatment, or serve as a predictive or prognostic indicator. In the next chapter, we
present a systematic study (HER2 Scoring Contest) on automated scoring of HER2
biomarker of invasive breast carcinoma cases.
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Chapter 3
A Systematic Study on IHC
HER2 Scoring Algorithms
The increasing importance of tissue-based biomarkers in stratified medicine [91] has
recently received significant attention in the domain of computational pathology.
Evaluating expression of the HER2 gene on IHC stained cases of invasive BC is a
key part of the diagnostic assessment mainly due to its recognised importance as
a predictive and prognostic marker in clinical practice [92]. This chapter presents
a systematic study of the automated HER2 scoring contest, held in conjunction
with the annual PathSoc meeting in Nottingham, June 2016, aimed at systemati-
cally comparing and advancing the state-of-the-art automated methods for HER2
scoring. In recent years, a number of systematic studies (competitions) have been
designed in the domain of computational pathology to speed-up the development of
artificial intelligence based diagnosis [32, 54, 82, 93, 94, 95]. This was the first-ever
contest organised on IHC stained WSI which makes it distinctive from previously
conducted studies, which were mainly based on H&E stained images. The algorith-
mic description of the automated methods presented in this chapter and in Appendix
A is provided by the teams participated in this systematic study. Our contributions
were more centred towards analysing/evaluating the presented results and designing
the overall workflow of this study.
HER2 is a protein that influences the growth of malignant epithelial cells.
The over-amplification of the HER2 gene is observed in BC cases having invasive
tumour regions. Cancer cells in HER2+ (positive) cases of BC encounter neoplastic
transformations which lead to uncontrolled growth of tumour cells as compared to
HER2- (negative) cases. Approximately all the invasive breast carcinomas cases are
recommended for HER2 testing [96] and nearly 20-30% of cases have over-expression
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Table 3.1: Recommended HER2 scoring criteria for IHC stained breast cancer tissue
slides [34].
Score Cell membrane staining pattern Staining assessment
0/1+ No membrane staining or in-
complete membrane staining in
< 10% of invasive tumour cells
(0+) OR faint/barely perceptible
or weak incomplete membrane
staining in > 10% of tumour cells
(1+)
Negative
2+ A weak to moderate complete
membrane staining is observed in
> 10% of tumour cells OR strong
complete membrane staining in
10% of tumour cells
Borderline
(Equivocal)
3+ A strong (intense and uniform)
complete membrane staining is
observed in > 10% of invasive tu-
mour cells
Positive
of HER2 protein [15] which is associated with poor prognosis, lower survival, and
high recurrence [97]. Recent studies have reported the HER2 status as a predictive
factor for anti-HER2 and hormonal therapies and also a prognostic factor to asso-
ciate invasive tumours with mortality and duration of recurrence free survival [92].
Therefore, precise quantification of HER2 over-expression is crucial for ensuring that
HER2+ patients receive appropriate anti-HER2 treatment.
Gene amplification can also be identified through Fluorescence In Situ Hy-
bridisation (FISH). Given the technical ease of performing IHC, it has become the
preferred test and FISH is usually only performed when the IHC is equivocal. In a
routine clinical practice, an expert histopathologist reports a score between 0 and
3+ and cases scoring 0 or 1+ are classified negative whilst cases with a score of
3+ are classed as positive. Cases with score 2+ are classified as equivocal and are
further assessed by FISH to test for gene amplification. Examples of the four differ-
ent HER2 scores (0 to 3+) are shown in Figure 3.1. A summary of recommended
guidelines for HER2 IHC scoring criteria [34] is shown in Table 3.1. Historically,
it was reported that up to 20% of the HER2 IHC results may contain inaccuracies
[98] due to variations in the technical quality and the subjective nature of scoring.
Although adoption of the HER2 guidelines and recommendations [34], have served
to improve standards in HER2 testing, there remain challenging cases especially
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Figure 3.1: Top to bottom: example of regions of interest from WSIs of the training
dataset.
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with HER2 scores deemed borderlines between categories. Automated IHC scoring
of HER2 carries a promise to overcome the existing problems in conventional meth-
ods. Automated scoring methods are relatively less prone to subjective bias and
can provide precise quantitative analysis which may assist the expert pathologist to
reach a reproducible score.
3.1 Materials and methods
3.1.1 Ethics
The ethics approval was provided by Nottingham Research Ethics Committee 2
[Approval No: REC 2020313]; R&D reference (N) 03HI01.
3.1.2 Image Data Acquisition and Ground Truth
The histology slides for this contest were scanned on a Hamamatsu NanoZoomer
C9600 enabling the scanned images to be viewed from a 4× to a 40× magnification,
making the process comparable to a clinicians standard microscope. The contest
dataset entailed 172 WSIs extracted from 86 cases of invasive breast carcinomas and
included both the H&E and HER2 IHC stained slides. The actual HER2 scoring
is normally done on the IHC stained slides whilst the H&E slides assist the expert
pathologist to identify the areas of invasive tumour and discriminate these from
areas of in situ disease. Figure 3.2 shows an example of the two types of WSIs (with
a corresponding zoomed-in region of interest) from the contest dataset.
The ground-truth was taken from the clinical reports issued on the cases
at a tertiary referral centre for breast pathology (Nottingham University Hospitals,
NHS Trust). At this centre, each case had been reported or reviewed by at least 2
specialist consultant histopathologists as part of their routine practice (preliminary
reporting and MDT review). The centre provides regular internal quality control
for HER2 assessment for immunohistochemistry runs and regularly contributes and
participates in the UK NEQAS (National External Quality Assessment Scheme) for
immunocytochemistry and in situ hybridisation (ICC & ISH).
3.1.3 Contestants
A total of 105 teams from more than 28 countries registered to access the training
dataset before the end of the registration deadline. By the end of submission deadline
(for the off-site contest), a total of 18 submissions from 14 teams were received for
evaluation. We provided an opportunity to each of the 14 teams for presenting their
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Figure 3.2: An example of WSIs along with a zoomed-in cross-sectional area showing
the tumour region (top) H&E stained slide, and (bottom) IHC stained slide.
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Table 3.2: Agreement points for predicted calls of ground-truth (GT).
Erroneous predicted scores
Ground Truth
Score 0 1+ 2+ 3+
0 15 15 10 0
1+ 15 15 10 0
2+ 2.5 2.5 15 5
3+ 0 0 10 15
Table 3.3: Bonus point criteria, when PCMS lies in a certain range of the GT value
of the PCMS.
Ground truth Percentage with Complete Membrane Staining (PCMS)
0 0 0
1+ 1 (PCMS <3%) 3 (PCMS ± 2)
2+ 5 (PCMS ± 5) 2.5 (PCMS ± 10)
3+ 5 (PCMS ± 5) 2.5 (PCMS ± 10)
approach in the contest workshop and 6 teams chose to present. For the Man vs
Machine contest, we received the markings from 4 pathologists. The contest website
was reopened for new submissions after concluding the workshop.
3.1.4 Evaluation Measures
The performance of each submitted algorithm was evaluated based on three crite-
ria: 1) agreement points, 2) weighted confidence, and 3) combined points. Each
assessment criterion has a separate leaderboard. The evaluation criteria were ratio-
nalised according to the clinical significance and implications of HER2 IHC scoring
as follows: in everyday clinical practice, for a score of 0 and 1+: No Herceptin is
offered to the patient; for 3+ score, Herceptin is offered. For an IHC 2+ score, a
FISH test is performed; if positive (i.e.) there is evidence of gene amplification and
Herceptin is offered while for a negative result, it is not offered. The evaluation
considers the impact of erroneous classification. For example, a score of 0/1+ being
interpreted as 3+ or vice versa is a serious error while a 2+ scored as 0/1+ denies
a few patients of valid treatment; a score of 3+ for a 2+ case bypasses the FISH
test and may erroneously treat few cases (which would have been FISH negative)
with toxic drugs while a score of actual 3+ downgraded to a 2+ calls for additional
expense of FISH testing but the end result will probably be the same and hence this
should not be regarded as that serious an error. These have been summarised in
Table 3.2.
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For agreement points, a penalty method was employed whereby each erro-
neous prediction is penalised with respect to its deviation from the GT as shown
in Table 3.2. In routine clinical practice, pathologist also estimates the percentage
of cells with complete cell membrane staining (PCMS) along with HER2 score. To
increase the objectivity in evaluating the automated algorithms, we devise a bonus
criterion as shown in Table 3.3, where the decision was made on the PCMS regard-
less of the intensity. The bonus points were primarily introduced for score 2+ and
3+ as they attain more clinical significance. For the IHC score 1+, 1 bonus point
was awarded if there was an accurate prediction of the IHC score and PCMS < 3%,
while 3 bonus points were awarded if there was an accurate prediction of the IHC
score and PCMS > 3% but the predicted PCMS value only deviated ±2% from
the GT. For the IHC scores 2+ and 3+, 5 bonus points were awarded if there was
an accurate prediction of the IHC score and PCMS only deviated ±5% from the
GT. Similarly, 2.5 bonus points were awarded for score 2+ and 3+, if there was an
accurate prediction of IHC score and PCMS only deviated ±10% from the GT.
For the development of an interactive diagnostic tool, it is important that au-
tomated algorithms identify such cases which require further examination by pathol-
ogists before concluding the final outcome. In this regard, we devise a weighted
confidence criterion that may indicate those cases where further examination is re-
quired. The criterion to measure the weighted confidence wc was distinct for both
truly and wrongly classified cases. In cases where the predicted HER2 score ps
matched with the GT with higher confidence c, the weighted confidence amplified
the confidence value for true prediction whereas wrong predictions with high confi-








The third assessment criterion is a combination of both agreement points
and weighted confidence based evaluations. The combined points were calculated
by taking the product of two assessment criteria for each case.
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3.2 Organisation
3.2.1 Stage 1: Release of the Training Data
In the first stage, the training dataset comprising 52 cases were released to the
registrants, through a secure website portal. The dataset consisted of IHC and
H&E stained images and the GT. The GT score and PCMS were released for the
training dataset. At this stage, most of the details regarding contest (like tasks,
contest rules, contest forum details, etc) were already posted to the contest website
and the registered teams started developing their automated algorithms for HER2
scoring. The registration process remained open for five weeks. We also created
a social-forum (a Google group) for the participants to share their queries and to
communicate with the organisers.
3.2.2 Stage 2: Release of Off-Site Test Data
A dataset comprising 28 cases was selected for the off-site testing. The test dataset
consisted of IHC and H&E stained WSIs, the GT for the test datatset was not re-
leased to the participants to ensure a fair evaluation. Source code for performance
assessment in both MATLAB and Python languages were also released to the regis-
trants. The registrants were given more than a month after releasing the test data
to finalise and submit their scoring methods for the announced tasks.
3.2.3 Stage 3: Submission of Results (Off-Site)
The deadline for submission of results for the test dataset was set to be a week before
to the contest workshop. Each team had to submit results in a comma-separated
values (CSV) file along with a maximum 2-page summary of their algorithms, a de-
scription of the experimental setup, and some preliminary results. The participants
were advised that the CSV file should contain the predicted HER2 score, the con-
fidence value for predicted score, and the PCMS for each WSI in the test dataset.
Each registrant was allowed to submit up to three sets of results. The submitted
results were evaluated but outcomes were not announced until the contest workshop
was held.
3.2.4 Stage 4: Contest Workshop
The contest workshop covered three main events: a) a brief talk from the organisers
and the participants where 6 teams were invited for a brief presentation to give an
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overview of their approaches and experiments, b) announcement of the comparative
results for both off-site, and c) for the Man vs Machine comparison as a part of
the on-site contests. The remaining 6 cases (of the 86) were used for an on-site
competition (although they were released one day before the contest workshop due
to the computational requirements of some of the automated algorithms and their




Comprehensive results comprising all the submissions for automated methods are
shown in Figure 3.3. The teams were sorted in descending order with respect to
the combined and bonus points based assessment. For the off-site contest, the total
possible points were 420 (28 cases with a maximum of 15 points each) whereas,
for weighted confidence, the maximum points were 28, 1 for each case. The top
three teams with respect to point based assessments were Team Indus, MUCS-1,
and MUCS-2 whereas, according to weighted confidence assessment the top-ranked
teams were VISILAB, FSUJena, and MTB NLP. The combined results rank the
top three teams in the following order: VISILAB, FSUJena, and Huangch. The
performance of top-ranked teams including bonus points and the trend for total
points (without the bonus points) can be seen in Figure 3.4. MUCS-1, MUCS-
3, CS-UCCGIP, and MTB NLP achieved equal points but MUCS-1 secured more
bonus points as their PCMS was more accurate as compared to the remaining coun-
terparts. Similarly, VISILAB and Rumrocks ended up in a tie where both teams
attained equal points but the VISILAB method was more precise in predicting
PCMS. Comprehensive tables for all three leaderboards are available for download
from the contest website1.
3.3.2 Summary of Automated Methods
Most of the automated methods (described in Appendix A.2) applied a supervised
patch based classification approach for solving this problem. The most common
pipeline was based on three main components: 1) pre-processing including some
sort of automated or interactive method to identify the potential regions of interest
for training the underlying model, 2) classification based on handcrafted or neural
1https://warwick.ac.uk/tialab/her2contest/outcome
53
Figure 3.3: A summary of results of all three assessment criteria for the automated
HER2 scoring contest, ordered by the combined points criterion.
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Figure 3.4: Combined results for top ranked teams with respect to agreement and
bonus points.The trend shows the significance of correctly predicting the percentage
of cell membrane.
network learned features, and 3) post-processing techniques to aggregate the HER2
score at WSI level and to estimate the PCMS. Deep learning, especially CNN based
approaches dominated as most of the methods were based on CNN. The majority
of the CNN architectures (Team Indus, MUCS-(1-3), MTB NLP, VISILAB, Rum-
Rocks, FSUJena) were inspired by state-of-the-art deep neural networks [52, 99].
In the pre-processing and patch extraction stage, most of the teams followed
the conventional thresholding techniques with a combination of morphological op-
erators. These techniques are computationally less expensive and generally work
well as background regions lack any texture contents in contrast with other tissue
components. The MUCS-(1-3), MTB NLP, VISILAB, and FSUJena manually probe
the regions of interest through some calibration or customised methodologies. These
methods aimed to pick the best possible regions for training their algorithm, gener-
ally without affecting the testing phase. To segment tissue regions, RumRocks team
implemented a deconvolutional neural network (DCNN) and a 2D CNN for selection
of patches based on their texture. The Huangch team performed mean filtering and
stain normalisation by using the control tissue intensity values to calibrate the stain
colour intensity as a pre-processing step.
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In the second step, most of the teams employed deep learning approaches
whereas other teams such as CS-UCCGIP and Huangch used shallow machine learn-
ing algorithms on handcrafted characteristic curves derived from pixel intensities.
Team Indus used a combination of data-driven and handcrafted features. They
combined the average control tissue intensity with activation maps of the last con-
volutional layer, before feeding them into fully connected layers. Some of the top-
ranked teams deployed off-the-shelf models such as Alexnet [52] and GoogLeNet [99]
for predicting the HER2 score. The FSUJena team computed a set of bilinear fea-
tures from the convolution activation maps of the AlexNet. The derived activations
contain the learned feature maps representing a d-dimensional w × h spatial grid.
This approach enables them to perform their analysis on top of the convolutional
features. In combination with standard approaches for data regularisation, MTB
NLP and RumRocks trained multiple models. The final HER2 score and PCMS
were estimated by averaging over all the models. Additionally, a wide range of data
augmentation and regularisation techniques were employed to overcome the over-
fitting issues. As in practice, the standard data augmentation techniques such as
affine transformations (e.g. rotation, flip, translation), random cropping, blurring,
and elastic deformations were applied to train the network. MUCS-2, MTB NLP,
and RumRocks extensively used the data augmentation techniques for improved
generalisation on unseen data.
In the final stage of post-processing and predicting the PCMS, most of the
teams employed standard image processing and shallow machine learning approaches
to the results attained from the last step. A Random Forest classifier was trained by
MTB NLP to produce the final class probabilities and to estimate the PCMS. FSU-
Jena simply used the mean tumour cell percentage as seen in the training dataset
for a particular class as an estimate. Team Indus was the only participants to used
both IHC and H&E stained slides to estimate the PCMS using standard image pro-
cessing approaches like contour detection, thresholding, and morphological features.
Nearly, all the proposed methods extract image patches from high magnifications
(10× or above) excluding MUCS and Rumrocks, as their proposed methods identify
ROIs from a lower magnification.
3.3.3 Man vs Machine
Organisation
One way of evaluating the automated algorithms for IHC (HER2) scoring is to
perform a comparative analysis between the assessment of expert pathologists and
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Table 3.4: Summary Results for the Man vs Machine event. The evaluation was
carried out according to the contest criteria as described in the Evaluation Section.
Rank Automated methods & pathologists Score Bonus Score+bonus
1 Team Indus 220 12.5 232.5
2 Expert 2 210 20.5 230.5
3 VISILAB 212.5 15 227.5
4 MUCS 1 205 20.5 225.5
5 Expert 1 185 10 195
6 Expert 3 180 13 193
predictions of automated methods for a handful of cases as compared to the scores
for those cases as agreed by at least two consultant breast-pathologists (GT). On
the day of the contest workshop, we organised an event called Man vs Machine. The
main aim of this event was to analyse the performance of the proposed methods and
to explore the disagreements among conventional and automated methods. This
kind of analysis can lead us to a more sophisticated protocol for automatic HER2
scoring and to overcome the inter- and intra-observer agreements that can be found
in normal practice.
This analysis was performed on a subset of 15 cases from the off-site test
dataset. We also set up an online web-page for the pathologists. The web-page
enabled the experts to load and navigate (including pan and zoom) through the
WSI of those cases. Both IHC (HER2) and H&E stained digital images were made
available to mimic the conventional scoring environment. We requested the expert
pathologists on the contest day at PathSoc to score each case by providing the HER2
score, PCMS and a confidence value.
Comparative Results
Table 3.4 summarises the overall evaluation scores achieved by top-6 participant
for this event. Each table entry gives the cumulative score for all 15 cases, which
indicates the overall performance. The agreement-points based assessment was used
to evaluate the performance of this event. In total, we received 4 responses from
expert pathologists and we ranked the top-6 submissions including the top-3 auto-
mated methods. From submitted responses, three participant pathologists reported
themselves as Consultant Pathologist and one as Trainee Pathologist and all three
of them marked breast pathology as a sub-speciality.
As can be seen in Table 3.4, one of the automated methods slightly out-
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performed the top-performing participant pathologist2. These results point to the
potential significance of automated scoring methods and the recent advancements in
digital pathology. Its worth mentioning that automated HER2 scoring algorithms
submitted in this contest are not ready to deploy in their current form, as they
will require extensive validation on a significantly large-scale data and also plenty
of input from experts to prepare the GT on the larger data.
Table 3.4 shows pooled data for HER2 scoring among top-3 automated meth-
ods, the scores from top-3 participant pathologists and comparison with the GT.
Table 3.5 was determined for the 15 cases selected from the off-site contest dataset.
On the basis of HER2 scores, a 100% agreement with the GT was observed for score
3+ among the participant pathologists and the automated methods. For the scores
of 1+ and 2+, there were disparities between the GT and the new scores. In all
cases except one, for both man and machine, the error resulted from overcalling the
score. Thus, for the score 1+, on 6/9 (67%) were overcalled as 2+ by humans whilst
4/9 (44%) were overcalled by the machine algorithms. For the score of 2+, 7/15
(46%) were overcalled as 3+ by humans whilst machines overcalled 1/15 (6%) as 3+
and 1/15 (6%) was undercalled as 1+. Clinically, the score of 2+ is critical, as in
routine practice, cases of score 2+ are recommended to go through FISH testing. Its
equally important to avoid predicting the score 2+ as 1+ or 0, cases such erroneous
prediction will deny the further assessment of HER2. As it can be seen in Table 3.5,
none of the cases with score 2+ was misclassified by the participant pathologists as
either 1+ or 0 whereas for one of the case an automated method wrongly predicted
a score of 2+ as 1+.
Most of the incorrect predictions by the participant pathologists were found
to be in cases where there was considerable heterogeneity. Two such examples
are shown in Figure 3.5 and 3.6. In tumour cells of HER2 score 2+, a pattern
of weak to moderate complete membrane staining is observed whereas, for score
3+, an intense (uniform) complete membrane staining is observed. Estimating the
complete membrane staining is a difficult and highly subjective process especially
for score 2+ and 3+, as it is extremely hard to pick up subtle differences in the
morphological appearance for those cases.
2The reported results are based on 15 HER2 cases so any change in the dataset or in evaluation
criteria may influence these results.
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3.4 Discussion
A major aim of organising this study was to provide a platform for computer sci-
entists and researchers to contribute and to evaluate the performance of their com-
puter algorithms for automated IHC scoring of HER2 images from BC tissue slides.
Automated scoring may significantly overcome the subjectivity found due to vary-
ing standards adopted by different diagnostics labs. There is a current wealth of
literature [100, 101] using individual platforms (both freely and commercially avail-
able) for digital analysis of HER2 in BC. This, however, was the first comparison
of platforms and algorithms and provides a pilot for an independent comparison of
computing algorithms for HER2 assessment on a benchmark dataset. Overall, the
contest highlights the wealth of potential carried by AI techniques for assessment of
IHC slides.
The contest training dataset was deliberately selected in a way that it con-
tained a reasonable number of cases from all HER2 scores, bearing in mind the need
for the training algorithms to learn features for each score. For the test dataset
(both off-site and on-site), the GT was withheld at the time of results evaluation.
Results showed that the automated analysis performed comparably to histopatholo-
gists. Many of the algorithms achieved high accuracy often close to the maximum.
Our main objective was to analyse the performance of algorithms based on clinical
relevance and hence the three particular evaluation criteria described above were
chosen. The evaluation criteria were decided according to the clinical significance
and implications of HER2 with the help of two pathologists, who were also involved
in organising this study. Although, agreement (Table 3.2) and bonus points (Ta-
ble 3.3) criteria involved clinicians input and may have clinical relevance but both
criteria were not inspired by any quantitative studies. One of our objectives in or-
ganising this study was to provide a publically available dataset for benchmarking
and accelerating the development of automated scoring algorithms. It is quite pos-
sible that other assessment criteria may influence the ranking (as given in Figure
3.3) of comparative results. Therefore, it would an added advantage if some sort of
statistical measure (like concordance metric) would also be incorporated along with
clinically relevant measures to evaluate the correlation between ground-truth and
predicted HER2 score.
The data from the Man vs Machine comparison showed that, reassuringly,
all participants (whether human or computer) correctly identified cases with the
GT score of 3+. This means that no-one in the category would have been denied
treatment. Similarly, for the cases with a score of 0 or 1+, although there was some
59
Figure 3.5: An example showing IHC stained WSI and zoomed-in cross sectional
areas with corresponding HER2 GT scores marked by expert pathologists and pre-
dictions from top 3 automated methods.
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Figure 3.6: An other example of WSI and zoomed-in cross sectional areas with
corresponding HER2 GT scores marked by expert pathologists and predictions from
top 3 automated methods.
61
overcalling, this never exceeded 2+ and thus none would have received treatment
without further testing. The most problematic category was, not unexpectedly,
cases with a score of 2+; in both human and machine evaluations. If overcalled as
3+, the FISH negative subset would be over-treated. The GT information for the
FISH results was not released to the participants as the contest was aimed just at
comparing the interpretation of HER2 IHC results. Hence, most of the automated
algorithms aimed at predicting the equivocal cases as 2+. Table 3.5 incorporates
the FISH results for all the cases that were marked as 2+ in the test data GT (in-
cluding Man vs Machine dataset). From Man vs Machine cases (15 in total), a score
of 2+ (subsequently FISH negative) was overcalled by the machines as 3+ in just
one instance (VISILAB). In contrast, on three occasions (subsequently FISH nega-
tive) the participant pathologists overcalled the score 2+ as 3+. Moreover, for the
remaining test dataset (13 cases), on three instances the score of 2+ (subsequently
FISH positive) were erroneously predicted as either 1+ and 0 by the automated
algorithms. Overall, the results indicate that further fine-tuning will be required for
2+ cases with AI. While it is encouraging that automated HER2 scoring algorithms
may have sufficient potential, as direct comparison to human diagnosis, it is proba-
bly worthwhile to reflect that the number of pathologists actually joining the contest
was small (only four) and it would have been better to compare the pathologists
assessment of the slides on a reporting microscope rather than a computer for a
fairer comparison to real-life practice.
Conventionally, expert pathologists often switch back and forth between the
IHC and H&E slides to map the invasive tumour regions for estimating the percent-
age of membrane staining. Beside one of the participants (Team Indus), most of
the algorithms reported in this chapter have avoided the use of H&E slides, though
one cannot rule out the significance of H&E slide for automatic detection of DCIS
regions. In addition, the task of predicting the PCMS is extremely subjective, as
the expert has to make estimation on the basis of physical appearance of the stained
invasive tumour region. The semi-automated methods could provide a comprehen-
sive quantitative analysis on selected regions of interest to assist the experts in
estimating the PCMS and HER2 score, especially on borderline cases. As HER2
immunoscoring relies not only on intensity but the completeness of membrane pos-
itivity, automated scoring may be helpful as demonstrated by Brgmann et al. [102]
who proposed scoring of HER2 based on an algorithm evaluating the cell membrane
connectivity.
This study shows that automated IHC scoring algorithms can provide a quan-
titative assessment of morphological features that may assist in objective computer-
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assisted diagnosis and predictive modelling of the outcome and survival. In the
context of breast histopathology, whereby almost all the invasive tumour cases are
considered for HER2 testing, an automated or semi-automated scoring method has
the potential for deployment in routine practice. Despite all these advancements,
several challenges remain for the AI algorithms to be optimised and to become part
of the routine diagnosis. It is worth noting that serious optimisation will be needed
for automated methods while processing a whole-slide image. Some methods re-
quired more than three hours per case, which, in the real-world of diagnostic service
delivery is not feasible. Another limitation of this contest was that the image data
were collected from a single site using a single scanner.
A potential extension would be to collect data from multiple pathology lab-
oratories with HER2 scores marked by different experts and images scanned using a
variety of different machines. This would also test the differences inherent in stain-
ing quality and appearance that may affect such procedures. Such enhancements
could significantly overcome the overfitting to one particular dataset that may occur
in the automated scoring methods. In moving across systems, other laboratories for
example, have acknowledged the challenges in reaching the optimum Aperio algo-
rithm parameters to provide results that were equivalent to those of the Automated
Cellular Imaging System (ACIS) or Cell Analysis System (CAS 200) quantitation
systems [103], which are fully automated environments for detecting cells based
on intensity characteristics and handcrafted features found in IHC stained images.
Therefore, there is a need to learn across comparative systems for which the current
study provided a valid starting point. Also, the study highlights the need of dialogue
between histopathologists and informaticians to understand correct identification of
tissue compartments relevant for assessment, correct morphology (normal vs in situ
vs invasive) and stromal stain vs tumour stain. Algorithms will also need to be
trained to the natural acceptable variation in staining hues and intensities (intra
and inter-laboratories) to work effectively during routine practice.
This contest provided a baseline for computer scientists and computational
pathology researchers to develop automated/semi-automated algorithms for scoring
HER2 WSIs. The contest has ended now but the registration and the web-portal is
open for future participants to make their novel contribution in automated HER2
scoring. It is worth emphasising that in general, for IHC scoring, the GT information
is only provided on the WSI level. However, computational pathology algorithms
usually require detailed annotated datasets to train the underlying model. Most
of the previously published automated IHC scoring methods and all the proposed
algorithms in this study were using some sort of pre-processing method to select
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potential ROIs for training. The inevitable fact is that such hand-crafted approaches
introduce a bias to the model predictions. With that in mind, in the next chapter, we
present an attention mechanism that overcomes this bias and automatically ignores


































































































































































































































































































































































































































































































Learning where to see:
Attention Model for Automated
IHC Scoring
Despite the recent progress that highlights the significance of image analysis in the
domain of computational pathology [32], there are several challenges that hinder
the adoption of algorithms in routine clinical practice. Computational pathology
algorithms usually require detailed annotated datasets to predict the slide label.
For the task at hand, the GT label for IHC score (HER2 score in our case) is
generally provided at the WSI level and there are no detailed annotations provided
about which ROIs from the tissue slides are consulted for the final HER2 score.
Amongst existing automated approaches, the simplest approach is to manually or
randomly extract patches from desired ROIs of a WSI and train a supervised model
to predict the required HER2 score. Such approaches introduce an inevitable bias to
the model predictions and disjoint selection of small patches may also suffer from the
loss of visual context. Another potential shortcoming is computational inefficiency,
as these models need to process all the regions of a given image, where some of the
tissue regions may not be diagnostically relevant for the prediction of the correct
IHC score.
With regards to the aforementioned challenges, we ask the question: can
we train a model that ignores the irrelevant information and learns where to see?
To answer this question, we propose a novel deep learning approach for automated
scoring of IHC stained HER2 slides of invasive breast carcinoma, based on the
concept of policy gradients. Given a large tile from a WSI, the proposed model
identifies some of the diagnostically relevant locations from a low resolution (2.5×)
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coarse representation of a given image by learning a parameterised policy over the
interaction sequences of ROIs locations. The model sequentially samples the multi-
resolution ROIs 40× and 20×, from the relevant locations to learn the discriminative
features for different HER2 scores (0 to 3+).
The core components of the proposed model are a residual convolutional neu-
ral network (ResNet) and a recurrent neural network (RNN). The role of ResNet in
this model is to learn discriminative features whereas the RNN sequentially anal-
yses the provided features to predict the outcome and the next location. Since
the GT information was only provided for WSI level with no prior knowledge of
ROI locations, we train the model with policy gradients. Our model is designed to
explore spatially distinct locations and learn features from visually discriminative
regions. In cognitive psychology, this phenomenon is known as inhibition of return
(IoR) [104] that prevents the previously attended regions to be attended again. Our
model incorporates the concept of IoR in order to encourage the model to attend
non-overlapping diagnostically relevant regions. Another important issue is that an
erroneous scoring of 3+ as 0/1+ or vice versa may have far-reaching effects for a
patient. In order to avoid such large errors, we propose a task-specific regularisa-
tion term that penalises such predictions. This study was conducted on a publicly
available dataset from the HER2 scoring contest (as explained in the previous chap-
ter) [41] containing 172 WSIs from 86 cases. Extensive experiments on the contest
dataset show the efficacy of our proposed model, for guiding deep learning models to
ignore irrelevant regions and scaling up to large images. The proposed method out-
performs all the 18 algorithms that participated in the HER2 contest, most methods
using state-of-the-art CNNs.
4.1 Related Work
Automated IHC scoring has been approached with a variety of handcrafted fea-
tures and deep learning based methods. The most common approach for automated
IHC scoring involves a pre-processing step to identify the potential tissue regions
for training the underlying model. Then, a handful of small patches are sampled
from selected tissue regions, either randomly or by using sliding window approach.
The identification of potential tissue regions is generally accomplished by manual
selection [105, 106], semi-automated [102] or thresholding based automated methods
[107]. The pre-processing step is generally followed by training a patch-based super-
vised model, to learn the discriminative features and predict the outcome of each
input patch. A range of hand-crafted [107, 108], approaches have been proposed to
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improve the IHC scoring of hormone receptors in breast cancer. For HER2 scoring,
Rodner et al. [109] recently proposed an algorithm that computes a set of bilinear
filters using convolutional layers. For classification of HER2 scores on patch level,
they use bilinear features to train a multi-class logistic regression model. A deep
neural network has been presented by Saha et al. [110] for HER2 quantification
by segmenting nuclei and cell membranes. Mukundan et al. [111] introduced a set
of characteristic curves by varying the intensity of saturation channel with a hand-
picked threshold for classification of HER2 score. The final step of HER2 scoring
in general involves aggregation of patch level scores to the WSI level score which
is typically done by finding the most dominant class within a WSI or by training
a shallow classifier on features selected from the output probability map of a WSI.
Supervised patch-based approaches have established well for problems where tissue
level GT is readily available. However, in IHC scoring where tissue level GT is
generally not available, it is imperative to explore how deep learning models can be
trained to ignore unnecessary information from the given image and focus only on
regions that eventually helps in predicting the correct outcome.
Recent studies have shown that DRL has been employed in widespread ap-
plications. For object detection, Caicedo et al. [112] proposed a deep Q-Network
(DQN) for multi-class object localisation. The model localises target objects by fol-
lowing a search strategy, which starts with analysing the input image and then the
agent guides the model to narrow down the field of view for precise object localisa-
tion. The reward function was calculated by computing the intersection-over-union
between the GT and the predicted bounding box for the object. This work was fur-
ther extended for medical images including automated anatomical landmark [113]
and breast lesion detection [114] for DCE-MRI images, whereby an agent localises
the potential ROI containing the lesion by iteratively adjusting the bounding box.
The reward function was computed by using the Dice coefficient between the GT and
the predicted box. There also exist some works that incorporate DRL for genomics
data to enhance the annotation of biological sequences in genome sequencing [115]
and construction of protein interaction network for prostate cancer [116]. Another
interesting extension is the incorporation of attention models with policy gradients
that enable the model to learn a parametrised policy based on spatial dependencies.
This combination has been explored for a number of applications including object
detection [117], action recognition [118] and image captioning [119]. However, hav-
ing precisely annotated GT for computing the reward function limits the use of deep
Q-learning for IHC scoring.
In this work, we treat IHC scoring as a sequential learning task to learn
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discriminative features and select informative regions within a large image tile of a
WSI. To the best of our knowledge, this is the first study that uses DRL for IHC
scoring of histology WSIs. In terms of policy learning methodology, our work has
some similarities to the methods proposed by Mnih et al. [120] and Ranzato et al.
[121]. Our proposed model contains a context module that incorporates the coarse
representation of input image, before predicting attentive locations. The end-to-
end inhibition of return (IoR) mechanism encourages the model to explore spatially
distinct attentive locations. Moreover, the scope of existing attention methods is
limited to relatively small natural images whereas tumours in IHC stained WSIs are
heterogeneous in terms of their morphological appearance, colour variability, shape,
and temporal locations.
4.2 Learning Where to See
Given an image I, the task is to predict the HER2 score ranging from 0 to 3+ by
selecting a set of diagnostically relevant regions as well as learning discriminative
features from those regions. The schematic diagram of the proposed model is shown







t ∈ I are regions of width 128 and height 128 sampled at the region centre lt
at different magnification levels 40× and 20×, respectively. The convolutional net-
work fc1 with learnable parameters θc1 analyses it and transforms it into a fixed
length feature vector vt ∈ Rm. The recurrent model fh with learnable parameters
θh sequentially processes the aggregated ROI features to update its internal state.
Besides, the context model processes the down-sampled version I↓16 (down-sampled
by a factor of 16 in both directions) of the input image and perform the IoR opera-
tion, as described in Section 4.2.4. The next location l(t+1) is predicted by analysing
the hidden state (fh(θ)h)) from the RNN that reflects where we currently are, and
the output v↓16 of CNN fc2, with learnable parameters θc2, that represents the con-
text. The whole process is repeated for T iterations and at the end of the sequence
(i1, i2, ., iT ), the model predicts the final output score YT .
This iterative process wrapped around an RNN model forms a classical
environment-agent interface that can be formalised by the partially observable Markov
decision process (POMDP). In the current setup, the RNN and CNNs collectively
act as a decision maker, which is formally known as an agent in the reinforcement
learning (RL) literature. The agent sequentially interacts with the environment,
which in our case is the image I. For each time step t, the agent receives a state
from the environment. It then processes the given state and responds with appro-
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Figure 4.1: The schematic diagram of our deep recurrent model. The regions of
interest sampled around lt at 40× and 20× are shown with blue and yellow dashed
bounding boxes, respectively. The dashed line in the recurrent model shows the T
sequential iterations.
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priate actions, which in our cases is the next location (l(t+1)), directing the model
where to see and eventually deciding on the HER2 score. Overall this process of
predicting the next location is partly stochastic and non-differentiable, requiring
the use of policy gradients. The ultimate task for an agent is to map the given
states into actions by learning a parametrised policy (π) through trial and error.
At the end of this sequential process, the agent receives a scalar reward R based on
its actions, which in our case is linked to correct prediction of the HER2 score as
described in Section 4.2.3.
At a high level, our model mimics the histopathologist practice treating a
given image as an environment and the histopathologist as an agent who acts as
a decision maker. Given the environment, the agent glances through different tis-
sue components at a high level (low magnification) and then selects certain visual
fields (ROIs) at low level (high magnification) to observe and store the relevant mor-
phological features into the memory. The agent repeats this process for a certain
number of iterations on different states to build an internal representation of the
overall environment before coming up with the final decision, i.e. assigning the final
score. For the sake of simplicity, in the remainder of this chapter, we refer to the
combination of RNN and CNNs as an agent and the selected ROIs as the state.
4.2.1 Sequential Modelling
The recurrent component (RNN) acts as the backbone of the proposed model. At
each time step t, the recurrent model updates the parameters of hidden states and





input to the RNN is vt, the CNN based feature vector for multi-resolution ROIs (it)
centred at location lt. The RNN model also updates internal states (memory) that
capture information from previous time steps. The output fh(θh) of the RNN model
is defined as below,
fh∗(θh∗) = f(ht−1, fc1(θc1); θh∗) (4.1)
fh(θh) = f(ht−1, fh∗(θh∗); θh) (4.2)
We choose long short-term memory (LSTM) [122] as a preferred choice for
RNN to learn spatial dependencies between the ROIs. LSTM has proven to be
more robust as compared to vanilla RNN and less likely to suffer from the problem
of vanishing gradients. An important task of the model is to predict the next
location l(t+1) by using v
↓16 provided by CNN and hidden representation fh(θh) of
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ROI images processed by CNN and LSTM. We computed the Hadamard product of
fh(θh) and v
↓16 to obtain a combined feature vector. Finally, the location module
fl(θl), linearly transforms the combined representation to predict the normalised
coordinates of the next location l(t+1)(x, y). During the training process, the model
eventually learns to encode the information from the past sequences and decide
where to see.
4.2.2 Residual Convolutional Network
In the proposed model, the convolutional network serves as a non-linear function
that maps a given RGB image into a fixed length vector representation. More
specifically, we are using a variant of residual CNN [122] that contains residual con-
nections to reroute the input information into deeper convolutional layers. Residual
blocks ensure the end-to-end training of deep models by preventing the gradient
from vanishing within lower layers of a CNN. It also enables the underlying model
to reuse the low level features along with deeper convolutional (high level) features.
For a given input pk, the residual block function is defined as below
pk+1 = σ(Fk(pk, wk) + q(pk)) (4.3)
where Fk(pk, wk) is representing a sequence of convolutional operations, wk denote
the trainable weights (biases are omitted), k represents the kth residual block of the
CNN, p(k+1) is the output of residual block and q(pk) = pk is an identity function.
The function σ(.) denotes a non-linear activation function, which in our case is a
ReLU. The Fk(pk, wk) + pk operation is representing element-wise addition of two
activation maps. A schematic illustration of the residual CNN is shown in Figure 4.2.
We use two residual CNNs, fc1 and fc2 where fc1 learns discriminative fea-
tures by producing a fixed length non-linear vector representation vt for further
processing by the recurrent network and fc2 incorporates the context information.
The input to fc1(θc1) is the corresponding ROIs (at 40× and 20×) sampled at lt(x, y)
from the input image I. The network separately processes the selected ROIs and
concatenates the feature representative of i0t , i
1
t . The concatenation operation is
previously used in [55] for a hierarchical CNN to combine the feature representa-
tion of corresponding up/down convolution layers. The CNN features of extracted
ROIs mainly assist our model to learn the discriminative patterns of different HER2
scores. The task for fc2(θc2) is to embed the contextual awareness within the pro-
posed model.
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Figure 4.2: A schematic illustration of residual convolution neural network.
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4.2.3 Model Training
The proposed model (Figure 4.1) is trained end-to-end by maximising the perfor-
mance over the parameters θ = (θc, θh, θl) of the residual CNNs, recurrent network
and the location module. By interacting with the environment, the model forms a
special case of the POMDP framework with an episodic sequence of states, actions,
and rewards. The task for the model is to learn a parameterised DRL policy (π)
that maps a given state into action(s) by maximising the sum of expected reward
while following the parameterised policy π. The parameterised policy π for calcu-
lating the probability of a certain action a from the action space A at iteration t for
a given state s with parameters θ can be defined as follows,
π(a|s) = P (At|St; θ) (4.4)
where St denotes the set of possible states at time t. Similarly, for the problem at
hand, the model needs to learn a parameterised policy π((l(t+1), Yt)|(it, I↓16); θ) to
predict the HER2 score (Yt) and coordinates of the next location l(t+1)(x, y), given
the selected ROIs (it) from lt(x, y) and down-sampled input image I
↓16. The model
receives a scalar reward rt after interacting with each selected ROIs (i1,2,..T ) of the
given image,
rt =





as provided in 4.5, where g denotes the GT score, Y
′
T represents the output of the
softmax layer and s denotes the output label. The total sum of reward is computed





where γ(t−1) is the weight factor for reward rt at time t. For a finite horizon
problem such as classification, we set γ = 1. Here the learning task is to optimise the
parameters θ that maximise the overall performance L(θ), associated with reward
rt. A straightforward approach for handling this maximisation task is by using
the gradient ascent. The update rule follows the standard back-propagation and is
defined as,
θn+1 = θn + α∇θL(θn) (4.7)
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where n is the iteration index and α is the learning rate. In order to maximise
L(θ), we employ the REINFORCE rule [123] from the class of policy gradients
to adjust the model parameters. In this episodic scenario, on average, the model
computes the gradients for actions that lead to higher rewards and consequently, the
log probability of actions with low rewards will be decreased. The policy gradient,











∇θ log π((lnt+1, Y nt )| (int , I↓16); θ)Rnt (4.9)
One limitation of the above formulation is that the model convergence can be
challenging if intra-class variance in the training dataset is relatively high. To gen-
eralise the policy gradient algorithm, we include a baseline function bt = Eπ[Rt] for






∇θ log π((lnt+1, Y nt )| (int , I↓16); θ)(Rnt − bt) (4.10)
4.2.4 Inhibition of Return
An important factor in adequate selection of diagnostically relevant regions is to
inhibit the model from visiting the previously attended regions. We observe that for
some of the selected locations during the sequential process, the sampled ROIs are
not spatially distinct. Figure 4.3 (1st column) shows three such examples where the
selected ROIs lie relatively close to each other, resulting in overlap with previously
attended regions without any significant performance gain. This argument also ap-
plies to images where the diaminobenzidine (DAB) stain expression is relatively
sparse as shown in Figure 4.3 (2nd row). A straightforward strategy to address this
issue would be to suppress the texture information [104] of previously attended loca-
tions that would encourage the model to rapidly explore spatially distinct locations.
This simple IoR strategy leads to the model giving higher priority to regions that
it has not previously considered for learning the discriminative features. The IoR
strategy is computationally efficient, widely studied in cognitive psychology [125]
and in sequential learning [104, 112].
Further, we introduced an additional constraint LIoR in the loss function. At
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Figure 4.3: Three sample images representing the effect of inhibition of return (IoR),
showing the selected ROIs without the IoR penalisation (Left) and with the IoR
penalisation (Right). As can be seen, the selected ROIs after the IoR penalisation
are relatively distinct from each other. Filled rectangular regions (black) show the
suppressed texture.
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the end of the iteration sequence t = (1, , T ), LIoR computes the overlap between
the coordinates of selected ROIs, penalising selection of image patches relatively
close to each other. The scope of IoR penalisation vanishes (its value becomes 0) if









rect[lt(x, y)] ∩ rect[lj(x, y)] (4.11)
where rect[lt] and rect[lj ] represent rectangular coordinates sampled from the input
image I and CT2 is the number of combinations of different ROIs, in turn helping in
limiting the intersection values between 0 and 1. The above loss function updates
the policy parameters to correctly predict the HER2 score by penalising the model
for locating spatially overlapping regions.
4.2.5 Task-Specific Regularisation
The clinical impact of large erroneous predictions of HER2 score is highly significant
and should be avoided as much as possible. Inaccurate prediction for patients of
score 0/1+ as 3+ will lead to giving treatment with toxic anti-HER2 drugs to
patients who do not need it, while predicting cases with score 3+ as 0/1+ will lead
to the patient not given the appropriate treatment needed. To avoid such scenarios,
we added a task-specific regularisation term.




T )− g| (4.12)
The final loss function combines the parameterised loss with task-specific regulari-
sation and IoR as given below,
L = Lθ + λ1Lsc + λ2LIoR (4.13)
where λ = λ1 +λ2 controls the sensitivity (scope of penalty) for both Lsc and LIoR.
For our experiments, we opted to keep λ1 = λ2.
4.3 Experiments and Results
4.3.1 Dataset
This study is conducted on a publicly available dataset from the HER2 scoring
contest, as explained in the previous chapter. The contest dataset consists of WSIs
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from 172 histology slides of 86 invasive breast carcinomas cases scanned using Hama-
matsu NanoZoomer C9600 at the highest resolution (40×), two slides per case (one
IHC stained with HER2 and another with the standard H&E). On average, each
scanned WSI contains more than 1010 pixels. The GT for the contest was marked
by a minimum of two expert histopathologists. For each case in the training dataset,
the GT consists of a HER2 score and a PCMS, both at the WSI level. The training
dataset is made of 52 cases, 13 cases from each HER2 score (0-3+) and the test set
consists of 28 cases. The remaining 6 cases were not included in the test/training
dataset and only reserved for the on-site part of the competition.
4.3.2 Experimental Setup
The ROIs were cropped at 40× and 20× resolutions, each ROI of size 128×128×3
pixels. The size of the input image I was 2048×2048×3 (471.1×471.1 µm2) sampled
at 40×. In total, we extracted 58,500 image tiles (with an overlap of 50%) from
the 52 training WSIs after tissue segmentation and a simple DAB intensity based
thresholding. The number of neurons in hidden layers of RNN was set to 256 and
128, respectively. The CNN transforms the given image into the feature represen-
tation of size 1×128. ReLU activation function was used after each residual block.
To overcome the overfitting problem, we performed data augmentation by random
rotations (0◦,90◦,180◦,270◦), horizontal and vertical flipping, and the transpose of
all the images in the training dataset. The regularisation parameter λ controls the
sensitivity of the task-specific regularisation and IoR penalisation. Through empir-
ical observations based on the validation data, we found that the best performance
was achieved with a value of 0.04 for λ , which we used for all the experiments. Some
other values of λ we used to evaluate the performance of the model are 0.01, 0.02,
and 0.06. The initial learning rate was set to 0.001 with exponential reduction of
0.97 and the momentum was adjusted at 0.9. The batch size was selected as 10. The
location of the first ROI was randomly selected. The number of ROIs per image was
selected as 6. The learning parameters were initialised as Gaussian random numbers
with 0 mean and 10−2 standard deviation and biases were set to 0.
4.3.3 Comparative Analysis
In this section, we discuss a variety of experiments to demonstrate the efficacy and
evaluate the performance of the proposed method. For the following experiments,
we performed 4-fold cross validation across 52 cases. We split the 52 cases into 4
subsets, with nearly equal representation of all four HER2 scores, and used 3 subsets
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Table 4.1: Acccomb denotes combined accuracy. In DAB ROIs, the locations were
randomly selected from the diaminobenzidine (DAB) regions.
Method 0 1+ 2+ 3+ Acccomb
RMVA 0.702 0.446 0.275 0.275 0.355
random ROIs, Lθ, Lsc 0.868 0.671 0.632 0.803 0.743
random DAB ROIs, Lθ, Lsc 0.822 0.615 0.677 0.874 0.764
Proposed - without context module 0.982 0.452 0.568 0.721 0.652
Proposed - Lθ 0.982 0.538 0.703 0.782 0.733
Proposed - Lθ, Lsc 0.963 0.532 0.721 0.825 0.753
Proposed - Lθ, Lsc, LIoR 0.919 0.772 0.661 0.837 0.794
for training and the remaining one subset for validation. The GT for the test dataset
is not publicly available and, in this section, we have reported the performance of
different variants of the proposed model on the validation dataset. We report the
results for the test dataset in Section 4.3.4. Generally, a large part of WSI contains
background (glass) regions with no tissue components. For tissue segmentation, we
perform local entropy filtering on a lower resolution (2.5×) version of the WSI.
Comparative Results
In this experiment, we evaluate the significance of different sub-components of the
proposed model, including Lθ, Lsc, and LIoR. Another important aspect is to evalu-
ate the significance of the parameterised policy for selecting relevant ROIs and how
it affects the performance if we select ROIs randomly instead of following a certain
policy.
For random selection of ROIs, we perform two main experiments: a) select
ROIs randomly from the entire I and b) select ROIs randomly from only DAB
regions of I. In the first approach of random selection, we predict the HER2 score
of given ROIs (it) and select the next location randomly without consulting the
context and current state of the model. Random selection correctly predicts HER2
score for images where most of the area is covered by discriminative tissue regions.
However, it is susceptible to selecting regions that contain mostly background and
sparse DAB regions. For the second approach, we perform stain deconvolution [126]
on I by estimating the stain matrix using [127]. DAB regions contain low luminance
and therefore for binarising the DAB channel using τ(IDAB), we empirically chose a
relatively high threshold value of 0.8. The τ(IDAB) is then followed by morphological
operations to exclude the noisy (small) components of the DAB channel. Table 4.1
shows the results for both experiments. Evidently, the second method is a relatively
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Figure 4.4: Example of four images with selected regions-of-interest (ROIs) pre-
dicted by our method, for each HER2 score (0-3+), respectively. The first column
shows the input images and coloured disks shows the predicted locations. The re-
maining columns show the selected regions at 40× and 20× around the selected
locations lt, t = 1, 2, , 6. The first selected region is shown with blue bounding box
and the last selected region is shown with red bounding boxes.
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Figure 4.5: Another example of four images with selected regions-of-interest (ROIs)
predicted by the algorithm. Correctly predicted HER2 scores are 1+, 3+, 2+, and
2+. The first column shows input images and coloured circles shows the predicted
locations. The first location is shown with blue bounding boxes and similarly the
last location is shown with red bounding boxes.
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direct way of selecting it and therefore yields higher performance as compared to
the first approach for random selection. However, it offers some limitations as
compared to the proposed model: the first major limitation is the absence of LIoR,
that enables the model to explore spatially distinct locations. The LIoR restrains
the proposed model from overemphasising particular locations by penalising the
learnable parameters and encourages the model to learn discriminative features from
different tissue regions.
One way of handling the absence of LIoR is to introduce a set of hard-
constraints for selecting spatially distinct lt(x, y). However, defining a set of gener-
alised hard-constrains is a non-trivial task and it may influence the model perfor-
mance on images where we have sparse DAB representation (3rd row of Figure 4.4).
The comparative analysis for combining randomly sampled ROIs with IoR could
be achieved by rejecting ROI samples where there is an overlap with the previous
ROIs. For the sake of simplicity, we have not performed such comparison with the
proposed method and it may be considered as a limitation of this comparative anal-
ysis. Secondly, it has no longer access to the overall I↓16 and the context module.
Consequently, this variant of our proposed model could be considered a departure
from the routine clinical practice, where a pathologist glances through a coarse rep-
resentation of input image at a higher level and then selects ROIs at lower levels
before concluding the outcome. Therefore, it is imperative to follow a parameterised
policy that incorporates the context and offers a temporal connection (via LSTM)
between the selected locations.
Further, we investigate the implications of the context module, task-specific
regularisation (Lsc) and IoR (LIoR). The context module allows the model to analyse
a coarse representation of the overall environment and use that to predict l(t+1)(x, y).
Existing attention based models [120, 128] including RMVA (recurrent model for
visual attention) have no mechanism to prevent models from revisiting the previ-
ously attended regions. Besides, RMVA also incorporates a strong location prior
to the model, which is irrelevant in histology image analysis mainly due to the
random orientation and morphological appearance of underlying tissue. Table 4.1
gives patch-based classification results of the proposed model with different settings.
Overall the results are in favour of the proposed method (Lθ, Lsc, LIoR). Figure 4.4
shows a sample of representative patches with selected ROIs. The most challenging
images were from HER2 class 1+ and 2+, where resemblance in morphological ap-
pearance was present due to tumour heterogeneity, as shown in 2nd and 3rd rows of
Figure 4.4. In Figure 4.4, the image patch for score 2+ contains relatively smaller
extent of DAB expression and most of the tissue region belongs to 0/1+. In that
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case, the model starts with a relatively less informative region and sequentially learn
to focus on the informative regions of the image to predict the correct outcome.
Number of ROIs
The aim of this experiment is to investigate the effect of number of ROIs for a
given image I. We evaluate the performance of the proposed model by using 4,5,6
and 8 number of ROIs. For this contest dataset, we observed the best performance
with 6 ROIs, as shown in Figure 4.6. One of the main reasons for relatively low
performance with 8 ROIs is the images containing tissue boundary regions, where
most of the image region is covered by background glass. Therefore, in those cases,
selecting more locations may confound the model in predicting the correct outcome.
Another interesting aspect is the reduction of inference time and gain in the overall
performance (as discussed in Section 4.3.4), in a conventional patch-based setting,
for a given image I of size 2048×2048×3 at 40×. The model needs to process all
64 ROIs (each of size 256×256×3). In contrast, the proposed model can predict
the HER2 score after consulting a handful of ROI patches accompanied with down-
sampled version of I. However, although computing time may not be the most
decisive aspect in clinical practice, it may be an important factor in high-volume
diagnostic settings and for high-throughput IHC screening.
Selection of multiple resolution regions
This experiment compares the performance of the proposed model for selecting a
suitable combination of magnification levels. We perform this experiment with three
sets of magnification levels including 40×, 20×, and 10×. We observed that for IHC
HER2 scoring, ROIs selected from 40× and 20× yield the best performance. The re-
sults for mean scoring accuracy for all 4 classes are shown in Table 4.2. ROIs selected
at higher resolutions offer more detailed information regarding HER2 expression at
cell levels. On the other hand, ROIs selected at 10× or lower magnification offer
more context information, but they are also more likely to contain background or
irrelevant tissue regions, including non-invasive haeamatoxylin stained regions.
Size of ROIs
The main objective of this experiment was to evaluate the performance of the pro-
posed model on different sizes of ROIs. After selecting the location lt(x, y), it is
worthwhile to quantify the extent of context required for predicting the correct
outcome. Recent studies in computational pathology have also emphasised the sig-
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Figure 4.6: Comparative results for different numbers of ROIs.
Table 4.2: Significance of context in the proposed method. Acccomb denotes com-
bined accuracy.
Method 0 1+ 2+ 3+ Acccomb
Proposed 40×, 20× 0.919 0.772 0.661 0.837 0.794
Proposed 40×, 10× 0.881 0.613 0.676 0.807 0.742
Proposed 20×, 10× 0.802 0.592 0.608 0.711 0.65
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Figure 4.7: Comparative results for different patch sizes of ROIs.
nificance of visual context [129]. We perform this experiment on three different
patch sizes, including 48×48, 64×64, and 128×128, with results in Figure 4.7. We
noticed the best performance with ROIs of size 128×128. As expected, the per-
formance of the proposed model increases with increase in the context. However,
in HER2 scoring, it is important to limit the ROI size to prevent the inclusion of
irrelevant tissue regions.
4.3.4 Contest Leaderboards
This subsection covers the description for scaling the patch level results to WSIs
and performance of the proposed algorithm on the contest tasks.
Contest Tasks
A detailed description regarding the evaluation criteria is explained in the previous
chapter. The performance of the proposed algorithm on the WSI level is evaluated
by using 3 different criteria, as suggested in the contest guidelines: a) agreement
points, b) weighted confidence and c) combined points. In agreement points, a
penalty method was introduced that assigned points between 0 and 15 to each case
based on the clinical significance of the difference in predicted and actual scores.
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To resolve tie situation in the first criterion, bonus points were also awarded based
on a correct prediction of PCMS. A weighted confidence was devised to estimate
the credibility of WSI results predicted by the algorithm. This measure may also
help in stratifying cases that need further input from pathologists. And finally, for
each case, a combined point was calculated by taking the product of the other two
assessment criteria.
PCMS Estimation
In routine clinical practice, a pathologist visually estimates the PCMS on the WSI
level, indicating the strength of invasive carcinoma cells stained to HER2 protein.
For our experiments, we split the WSI into manageable image tiles I, depending
on the computational resources. The model then predicts a HER2 score for each
image tile and aggregates the results on the WSI level by simply choosing the most
dominant class as the HER2 score s =argmax(s0; s1+; s2+; s3+) where s0; s1+; s2+;
s3+ represent the number of image tiles predicted as 0, 1+, 2+, and 3+, respectively.
The PCMS for invasive breast cases was estimated by the WSI output maps. For
each score map, we simply compute the ratio between the area covered by each
predicted score over the total area of tissue region within the WSI.
Combined Leaderboards
One of the most challenging aspects in analysing histology images is to limit the au-
tomated analysis to diagnostically relevant tissue parts. A fully supervised method
processes the given image regardless of noisy or irrelevant contents. In contrast,
recurrent models can appropriately tackle such scenarios by only processing the rel-
evant ROIs. Figure 4.5 shows some of the visual results on the image patches from
the validation dataset. Table 4.3 reports the WSI level performance of the proposed
method on all 3 evaluation criteria. It also contains the results of top-10 perform-
ing algorithms in the contest. The proposed method ranked as 1st amongst all 18
submissions in the contest, including the combined points criterion and point based
scoring. The contesting algorithms were based on a wide range of the state-of-the-
art deep convolutional networks including GoogleNet [99], AlexNet [52] and LeNet
[130]. On 28 WSIs from the test dataset, the proposed algorithm correctly classified
26 WSIs. The most difficult cases were from borderline class 2+ and 3+. Both the
false predictions belonged to those classes. It is worth noting that the scores of 2+
and 3+ are the most difficult to call for expert histopathologists as well. On the
other hand, the proposed model correctly predicted the scores of 12 out of 14 WSIs
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The proposed method 405 419 24.1 359.1
VISILAB-I (GoogLeNet [99] ) 382.5 404.5 23.55 348
FSUJena [109] 370 392 23 345
HUANGCH (AdaBoost) 377.5 391.5 22.62 345.7
MTB NLP (AlexNet [52]) 390 405.5 22.94 335.7
VISILAB-II (contour analysis) 377.5 391 21.88 322
Team Indus (LeNet [130]) 402.5 425 18.45 321.4
UC-CCSE [111] 390 395 21.07 316
MUCS-III [106] 390 411 20.43 300.8
HERcules (SVM) 360 380 20.57 295.6
MUCS-II (GoogLeNet [99]) 385 413 19.51 290.1
with scores 2+ or 3+.
4.3.5 Glyoxalase-1 protein (Glo1) Scoring
In this experiment, we evaluate the performance of the proposed method on IHC
stained gastroenteropancreatic neuroendocrine tumours (GEPs). The over-amplification
in glyoxalase-1 protein (Glo1) is associated with resistance in multidrug tumour
chemotherapy [131]. In routine practice, an expert pathologist visually examines
IHC stained GEP slides and reports a score between 1+ and 3+, which represents
weak, moderate and intense Glo1 immunostaining, respectively. This experiment is
conducted on 82 WSIs from 39 patients with 25 midguts and 14 pancreatic cases,
with a total number of 22, 33 and 27 WSIs scored by an expert pathologist as 1+,
2+ and 3+ respectively. Further details regarding the dataset and GEP tumours
can be found in [132].
The main objective of this experiment is to test the efficacy of the proposed
IHC scoring method on another IHC stain by quantifying the concordance between
the pathologist GT score and Glo1 score predicted by the proposed method. We
first split the dataset into two folds and perform cross-validation by selecting half
of the dataset for training and the remaining half for testing. We then repeat the
experiment by swapping the training and test datasets. For each fold, the training
dataset was further spilt into training and validation subsets by selecting 35 WSIs
for training and remaining 6 (15% of the training data) for validation. Tissue regions
from WSIs were segmented by performing local entropy filtering on a lower resolution
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Figure 4.8: (a) Description of the number of Glo1 scoring WSIs (b) confusion matrix
for the proposed method and (c) confusion matrix for the hormone receptors scoring
(HRS) method [108].
(2.5×) version of the WSI. To avoid the class imbalance problem, we extracted all the
image tiles (containing tissue) from 1+ WSIs and randomly sampled equal number
of image tiles from classes 2+ and 3+. In total, we extracted 86,700 tiles each of size
2048×2048×3 at 40×. We then retrained the proposed model by retaining the same
data augmentation methods and hyperparameters (including learning rate, lambda,
number of ROIs, etc.), as explained in Section 4.3.2. Optimal weights were selected
based on the validation set. The final Glo1 score on the WSI level was estimated
by aggregating the scores of image tiles, as explained in Section 4.3.4.
Figure 4.8 shows two confusion matrices (CF) containing WSI results of Glo1
scoring. The CF in Figure 4.8(b) shows the results for the proposed method and
the results for automated hormone receptors scoring (HRS) method [108], which
was initially used in [132], are shown in Figure 4.8(c). The overall agreement be-
tween the GT and the proposed method is 81.7% (Glo1 scores for 67 WSIs were
correctly predicted), whereas the agreement is 60.9% in case of HRS. For IHC scor-
ing, HRS relies heavily on pixel intensities for quantifying the chromatin and protein
content. Therefore, heterogeneous morphological characteristics of neuroendocrine
cells within tumour regions pose the risk of confusing the algorithm in extracting the
desired features for IHC scoring. Figure 4.9 shows some of the qualitative results on
image tiles with different Glo1 scores. Overall, it is encouraging that the proposed
method outperforms the HRS with a noticeable margin. It is worth mentioning that
the performance of the proposed method may improve by appropriately tuning the
hyperparameters. Our intention here is to demonstrate to some extent the general-
isability of the hyperparameters selected from HER2 scoring. The IHC scoring of
HER2 and Glo1 cases have some fundamental similarities: a) in both cases the GT
was provided on the WSI level and therefore, it is imperative that the underlying
model learns a stochastic policy and identifies some of the diagnostically relevant re-
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gions in predicting the final outcome, and b) similar to HER2 scoring, an erroneous
scoring of 1+ as 3+ or vice versa may have far reaching effects for a patient. It is
somewhat necessary to have a mechanism that penalises the learnable parameters
for overcalling those classes. We also observed that in some tissue regions, cells
are densely packed and pose difficulties for the model in selecting ROIs from the
invasive tumour regions.
4.4 Discussion
With the adoption of digital slide scanners in routine pathology labs, large-scale
WSIs or virtual slides (1010 pixels) have emerged as a reliable alternative to con-
ventional glass slides [86]. Typically, for effective training of deep learning models,
it is incumbent to train computational models with large-scale precisely annotated
regions. The ineludible fact is that sourcing precise high-resolution annotations of
scanned slides is a laborious task and not considered as a part of the routine clinical
practice. Hence, attaining tissue-level annotations for a significantly large dataset is
one of the factors that may delay the acceptability of automated methods in clinical
practice [29].
This study proposes a novel recurrent model for IHC scoring of HER2 slides
of breast cancer. In some respects, the model mimics the pathological behaviour
by learning a parameterised policy to select diagnostically relevant regions. Experi-
mental results conducted on a challenging contest dataset demonstrate the efficacy
of the proposed model by outperforming the state-of-the-art methods, as shown
in Table 4.3. It is worth noting that the proposed model only identifies a small
number of regions required for predicting the correct outcome. Depending on the
requirements, the model can be extended to assign different scalar rewards to each
selected ROI. Different rewards may also be interpreted as the significance of each
selected ROI. Nevertheless, a challenge remains in that sometimes the model selects
regions that may not appear to be diagnostically relevant (e.g., non-invasive tumour
regions) due to tumour heterogeneity. An example is shown in Figure 4.4, the last
location of score 1+.
In computational pathology, diagnostic efficiency may be based on two main
factors: 1) selecting potential ROIs from a given WSI, and 2) extracting discrim-
inative features from within the selected ROIs. Some studies on eye movement
have shown that with the passage of time trainee pathologists eventually gain ex-
perience in the selection of diagnostically relevant ROIs and learn discriminative
features [133]. Another recent study [134] shows that the overlap ratio between
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Figure 4.9: Sample of four IHC stained Glo1 images with selected regions-of-interest
(ROIs) predicted by our method. Coloured disks show the predicted locations and
the sequence is as follows: blue, cyan, yellow, magenta, green, and red.
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ROIs selected by different pathologists is associated with higher diagnostic accu-
racy. An interesting extension of our work would be to find correlation between the
diagnostically relevant ROIs selected by machines and experts. This may help in
evaluating the diagnostic reliability of computer-assisted diagnostic systems. The
proposed model also offers several advantages over the conventional fully supervised
approaches. First, the model is capable of handling unwanted background regions
that are often quite common in histology images due to several non-standardisation
factors in slide preparation. Second, the proposed model is capable of scaling up
to WSIs or significantly large tiles of a WSI as the number of trainable parameters
are directly linked with the size of ROIs instead of image tiles. However, in order
to perform end-to-end training of the proposed model, we need the uncompressed
representation of all required tiles of a WSI to be hosted into the memory and it is
worth mentioning that on average, a 24-bit representation of an uncompressed WSI
at 40× requires approximately 56 GB [35] of memory, making it intractable to load
an entire WSI into the GPU memory.
The scope of the proposed model is not only limited to HER2 antibody
quantification. The scoring of other prognostic and predictive markers like ER, PR,
and proliferation of Ki-67 on the WSI level may also be possible with a similar ap-
proach. Last year iIn the United States alone previous year (2018), it was expected
that there will be 266,120 new invasive BC cases1. Whereas visual examination of
histological specimens is generally influenced by subjectivity measures for learning
discriminative features. The proposed model may assist experts in reducing subjec-
tivity and serve as a semi-automated tool to find diagnostically relevant regions that
may require the pathologist attention. Until now, we have described our proposed
automated tools for cancerous regions of H&E and IHC stained histological images.
During tumour progression, tumour stromal regions also experience structural vari-
ations and in the next chapter, we will describe an automated method that performs
proximity analysis of tumour and stromal (collagen) regions and their significance for






Tumour-associated macrophages, tumour infiltrating lymphocytes and immune check-
point expression have all been associated with tumour behaviour [25, 26, 135]. In
contrast, there are a limited number of studies that have investigated the role of
the acellular stromal microenvironment on outcome in diffuse large B cell lymphoma
(DLBCL) [136]. Stromal gene expression signatures and extracellular matrix compo-
nents such as fibronectin have previously been associated with outcome in DLBCL.
Collagen is an important component of the acellular stromal microenvironment, and
the presence of particular collagen subtypes has been linked to outcome in other can-
cers, including both urothelial and colorectal carcinoma [27, 137]. These findings
warrant further investigation of the role of collagen in DLBCL.
In this work, we investigate the spatial proximity of tumour cells and col-
lagen VI in DLBCL and describe a novel digital proximity signature (DPS), which
serves as a marker of regions of the tumour likely to be enriched for active collagen
signalling. The core components of the proposed framework involve: a) cell de-
tection and classification, b) selection of collagen points and c) estimation of DPS.
Figure 5.1 shows an example of a ROI selected from a DLBCL WSI and Figure 5.2
represents some exemplar tumour and normal cells. In this regard, we propose a
novel deep learning framework, Hydra-Net, for simultaneous cell detection and clas-
sification, enabling the end-to-end learning on a multi-task problem. During testing,
we introduce a multi-stage ensembling predictor that combines cell detection and
classification predictions by leveraging information about the local neighbourhood
of cells. The comparative analysis of cell classification demonstrates the efficacy of
Hydra-Net over single-task learning models. The tumour-collagen proximity analy-
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Figure 5.1: Example of a region of interest selected from diffuse large B-cell lym-
phoma whole-slide image.
sis is then performed by aggregating the tumour cell statistics within the vicinity of
collagen VI. We further show that strongly associated tumour-collagen regions are
linked with OS in DLBCL patients. To the best of our knowledge, this is the first
study that employs automated analysis to identify prognostic factors in DLBCL.
5.1 Related Work
Computational pathology has paved the way for histology based patient survival
analysis. Recently, Zhu et al. [138] studied geometry and texture features to de-
tect and segment cells in non-small cell lung cancer (NSCLC). Selected handcrafted
features were fed into a supervised principal component regression model to im-
prove predictive performance. Weng et al. [139] demonstrated that histology-driven
imaging data can better describe the tumour morphology and outperformed con-
ventional biomarkers for predicting survival in NSCLC patients. They employed
a deep learning model for cell sub-type classification and imaging biomarkers were
then identified using cellular features. More recently, a survival analysis based on
whole slide histopathological images survival analysis (WSISA) framework of glioma
and NSCLC cancer patients was performed [140]. They trained a deep learning sur-
vival predictor to aggregate the patient-level predictions from clustered data. One
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Figure 5.2: Example of tumour and normal cells from diffuse large B-cell lymphoma.
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of the potential shortcomings of prior approaches has been the random selection
or uniformly sampled visual fields for survival analysis. The inevitable fact is that
randomly sampled regions may not be strongly associated with disease outcome
or may belong to a certain region of a WSI. In contrast, we computed summary-
level statistics from the entire WSI and define a novel tumour-collagen proximity
signature.
Regarding cell detection and classification, a variety of recently proposed
methods handle cell detection and classification separately. Ciresan et al. [141] pre-
sented a deep learning based vanilla classifier to discriminate between mitotic and
non-mitotic cells in breast histopathology images. Sirinukunwattana et al. [142]
proposed a locality sensitive deep learning framework to separately tackle the cell
detection and classification on colorectal adenocarcinoma histology images. More
recently, Koohababni et al. [143] applied a mixture density network that maps the
image tile into a probability density function to sample the observed locations of
cells. The distribution of cells within the image is modelled using a mixture of Gaus-
sians, where parameters are learned through back-propagation. Unlike previously
published approaches, the proposed model unifies these two tasks into one model.
5.2 Methods
5.2.1 Hydra-Net: Cell Detection and Classification
Model Description
Given an image patch in ∈ RH×W×D with height (H), width (W ), and depth (D),
where image tile, I = {(in)}Nn=1, our model utilises the deep convolutional features
to simultaneously predict the class probabilities ckn, where k is the number of classes,
and the centre location ln(x, y) of a cell.
Figure 5.3 illustrates the proposed Hydra-Net architecture. The in is pro-
cessed by a stack of convolutional layers (CL) followed by a ReLU activation func-
tion. For classification, we use convolutional kernels of relatively small receptive
fields including 2 × 2 and 3 × 3 kernels, whereas stride for all CLs is adjusted as
1 pixel, preserving the spatial resolution after the convolution operation. The last
pooling layer is followed by a spatial dropout layer and the softmax classification
layer that predicts the label of each in into c
k
n where k ∈ {1, 2, 3}, including back-
ground (with collagen regions), normal and tumour classes. The other head of the
Hydra-Net is responsible for predicting the centre of each cell ln(x, y). The interme-
diate convolutional features are fed into the attention module that enables the model
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Figure 5.3: (a) A schematic illustration of our proposed Hydra-Net and (b) descrip-
tion of different sub-components.
to learn the structural dependencies lie within the provided activation maps. We
use a simple yet effective sigmoid (or soft) attention layer, which can be represented
as Cp = fp(Cp−1, wp) and A = Cpσ(Cp), where  denotes the Hadamard product,
A denotes the output of the attention layer, Cp represents the convolutional features
from the pth layer with wp trainable weights (biases are omitted). The output of
the attention module is further processed by a group of convolutional and a fully
connected layer of 512 channels.
Model Training
The learning mechanism of the Hydra-Net jointly optimises the combined loss func-
tion for multi-class cell classification and regression to predict the location tuple. It
optimises 3 different types of weights w = (wc,wr,ws) including cell classification,
regression and shared multi-task learning (MTL) weights, respectively. The param-
eters ws are jointly optimised for both the tasks, and the parameters wc and wr
are optimised by using the combined loss L as defined below,
L = Lc(c, c
′) + λLr(l(x, y), l
′(x, y)) (5.1)
where Lc(c, c
′) represents log loss for true class c′i. The second part of the loss
function is formulated over the true centre location of a cell l′(x, y) and the predicted
location l(x, y). The Lr is the l1 norm between the true and predicted locations,
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which is more robust to outliers as compared to the l2 norm. Preferably, we want our
model to predict location only for image patches that contain cell, and generally,
for background patches, there is no information provided regarding the l′(x, y).
Therefore, during training, we introduced a flag λ that is set to 1 for tumour and
normal classes and 0 for the background class. During inference, each in is processed
by a multi-stage ensembling predictor (MEP).
Multi-stage Ensembling Predictor
During test, we use the sliding window strategy with a fixed stride to extract
{(in)}Nn=1 for a given I. In general, ensemble strategies assist in better under-
standing of data distribution and overcome the generalisation error [144, 145]. We
split our dataset into 3 sub-groups and for each sub-group we separately train the
Hydra-Net (f(in)). Each in is processed by a multi-stage ensembling method, as
shown in Figure 5.4. Similarly, each sub-group model (f1(in),f2(in),f3(in)) sepa-
rately predicts cell location and class probabilities. For background patches, the
ln(x, y) information is irrelevant and therefore, for follow-up analysis we only con-
sider in where argmax(c
k
n) 6= 1 (background class). Further, we defined a probability
map în ∈ RH×W×D for the output (ln(x, y), ckn) of each sub-group as below
în = g(c
k
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n) is a weight that represents the height of în and l̂(x̂, ŷ) denotes the spatial
coordinates of în.
The value of în is 0 if the spatial coordinates lie outside a predefined radius
r, for our experiments, we set the radius as 9 pixels. Certainly, în has the highest
value at the predicted ln(x, y), which denotes the centre of a cell. To aggregate
în from all the sub-groups, we compute the pixel-wise average over the computed
probability maps. The final results on Î = {(̂in)}Nn=1 is obtained by an empirically
chosen threshold, which in our case is 0.45.
5.2.2 Digital Proximity Signature
Computation of DPS is based on two core components: a) select a set of reference
points G = {Gm}Mm=1 within the collagen regions, where M is the number of sampled
points, and b) perform proximity analysis between tumour cells and Gm.
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Figure 5.4: An illustration of the multistage ensembling prediction strategy. The
coloured rectangular boxes in input image show different in using a sliding window
strategy.
Collagen Localisation
The main objective of localising Gm is to select a set of representative points from
the collagen regions. One straightforward approach is to randomly sample M points
from the collagen regions of I. The major pitfall of following such a method is that
we may end up selecting Gm from a particular region of I or they may lie close
to each other. However, for proximity analysis, it is crucial to sample Gm from
spatially distinct regions of I. Therefore, we first segmented the collagen regions by
performing stain deconvolution separating I into 3 channels, Haematoxylin, DAB,
and background. Collagen VI antibody generally binds with DAB channel having
low-intensity values and therefore we empirically choose a relatively high threshold
τ = 0.82 to binarise the DAB channel IDAB. The highlighted region in Figure 5.5(C)
(teal colour) shows the segmented collagen region. We then compute the medial axis
of IDAB(τ) to retain the connectivity structure of collagen fibre, as defined below
Z = (IDAB(τ)	 tS)− (IDAB(τ)	 tS) ◦ S (5.3)
where 	 and ◦ denote the morphological erosion and opening respectively, and S
is the structuring element with size t. Further, we split Z into small grids of size
p × p, where Z = {(zm)}Mm=1 and p = 256. The next task is to select a Gm from
each zm, in this regard, we compute the Euclidean distance between the centre
point zm(p/2, p/2) and the spatial coordinates of medial axis zm(xα, yα), where α
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Figure 5.5: (a) Given image I with p×p small grids, (b) a zoomed-in region from I,
(c) highlighted region shows collagen segmentation, black-dashed circles represent
different proximity regions for DPS, red disks shows predicted tumour cells and (d)
extracted frequency features.
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represents the total points in medial axis, as given below












where E(.) denotes the Euclidean distance. Finally, the collagen region lying close
to the centre of zm is selected as the reference point, as shown in Figure 5.5(c).
Collagen-tumour Proximity Analysis
For each Gm, we compute a set of frequency features by counting the number of
tumour cells within its vicinity, as shown in Figure 5.5(d). The implicit advan-
tage offered by frequency features are rotation, translation, and scale invariance.
Similarly, we compute the features for the entire dataset ω = {(ωη)}νη=1, where ν
represents the number of collagen reference points from all the WSIs of the dataset.
We then perform clustering on the computed features in order to assign labels to
the segmented collagen regions.
We use a simple yet effective method, k-means clustering (k = 4) to arrange
the frequency features into clusters. The algorithm randomly selects the first cen-
troid and the remaining centroids are chosen based on the largest minimum distance
to the preceding centroids, as defined below
η̂ = argmaxη
(
minκ ‖ωη − Sκ‖22
)
(5.5)
where Sκ denotes the centroid of the κ
th cluster. The algorithm iteratively updates
the cluster centroids by computing the distance between centroids and the data
points using the Jensen-Shannon divergence, as defined below
JSD(Sκ ‖ ωη) =
1
2
KLD(Sκ ‖ Ω) +
1
2
KLD(ωη ‖ Ω) (5.6)
where KLD represents Kullback-Leibler divergence and Ω =
1
2
(Sκ + ωη). On the
basis of clustering results, we assign the clustering labels to the collagen region in
the vicinity of Gm. We further normalise the clustering labels to limit their values
between 0 and 1. Finally, in order to compute the DPS, we split the normalised
clustering labels into 4 categorises and individually aggregate the statistics. The
categories include very weak, weak, moderate, and strong association between tu-
mour and collagen regions. The qualitative results of proximity analysis and its
corresponding DPS can be seen in Figure 5.6. Our main intuition of identifying
DPS into 4 categories is to provide a concise summary of statistics regarding the
proximity between tumour and collagen across the WSI.
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Figure 5.6: (a) A sample visual field extracted from a whole slide image, (b) high-
lighted collagen regions demonstrate the association between collagen and tumour
(c) shows the area marked by rectangles in (a) and (b).
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5.3 Experimental Results
This study was performed on two cohorts of DLBCL, each containing 32 and 27
patients. The selected cases contain histopathologist-verified DLBCL WSIs stained
using immunohistochemistry for collagen VI with a Haematoxylin counterstain to
simultaneously detect collagen VI and nuclear morphology. Paraffin embedded sam-
ples of DLBCL (obtained from the UHB Trust, Birmingham, UK and approved by
National Research Ethics Service, UK: REC reference 14/WM/0001) were analysed
by immunohistochemistry, using citrate buffer antigen retrieval method. The slides
were scanned at a pixel resolution of 0.275µm/pixel (40×) using an Omnyx VL120
scanner. We separately report the results of the Hydra-Net and OS analysis with
tumour-collagen DPS.
5.3.1 Cell Detection and Classification
The GT for cell detection and classification was collected in 9 cases and marked
by an expert. In total, we get 2,617 annotated cells including 2,039 tumours, 462
normal and 116 macrophages. To mitigate the effect of sparse (and limited) GT,
we extensively perform the data augmentation by random rotations, cropping, flip-
ping (horizontal or vertical axis), and perturbing the colour distribution, attaining a
total of 30,416 patches including 12,100 tumour cells, 9,957 normal cells (including
macrophages), and 8,359 randomly selected background patches. Generally, tumour
cells and macrophages exhibit a high degree of morphological resemblance, having
weakly stained boundaries and hollow structure. For multi-class cell classification
task, we used micro averaged F1-score (the other variant is macro averaging) to
compute the classification performance. Generally, for imbalanced data micro aver-
ages are preferred over macro averages for multi-class problems. In micro averaging,
we combine the individual true positives, false negatives, and false positives of each
class and compute the micro averaged precision and recall.
We performed 3-fold cross-validation by selecting 2 folds of the dataset for
training and the remaining fold for testing. Table 5.1 reports the quantitative re-
sults for cell detection and classification, whereas Figure 5.9 shows the prediction
accuracy for each class with image patch I of size 51× 51 and 61× 61. The model
has not only identified the tumour and normal cells but it has also distinguished
background(collagen) patches (as shown in Figure 5.9). Our results suggest that
for the cell classification task, the patch size 51 × 51 yields the best performance.
The patch size 61× 61 offers more context information, but they are more likely to
contain irrelevant collagen tissue regions which may confound the model in predict-
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Figure 5.7: Cell detection and classification on an unseen image tile of a DLBCL
WSI. Detected tumour cells are phenotyped as red disks and normal lymphocytes
including macrophages are represented as green. (a), (b) and (c) shows the overlaid
results on the image tiles at different magnification levels. The blue rectangle in (a)
representing the region shown in (b), and (c) contains the zoomed-in region from
(b), as shown with the blue rectangle. The cell detection and classification was
performed on 40× magnification using the proposed Hydra-Net.
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Figure 5.8: Results of collagen-tumour proximity analysis on the whole-slide image
(WSI) and the estimated digital proximity signature.
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Table 5.1: Comparative analysis for cell detection and classification
Cell Classification
Methods Precision Recall F1-score
CRImage[146] 0.674 0.689 0.681
Super-pixels[147] 0.729 0.708 0.713
SC-CNN[142] 0.834 0.802 0.817
Hydra-Net without attention 0.828 0.825 0.826
Hydra-Net 0.839 0.842 0.84
ing the correct class of the given image. It is encouraging that the proposed MTL
framework outperformed the other competing methods by a reasonable margin. To
ensure a fair comparison, we retrained the selected algorithms on our dataset with
the same number of image patches after augmentation. Figure 5.7 shows the detec-
tion and classification results on a large tile of a WSI where overlaid colour disks
representing normal and tumour cells. Overall, the proposed Hydra-Net produces
fewer false negatives as compared to other methods. Table 5.1 also highlights the
significance of soft attention layer, which is computationally efficient and enables the
model to focus only on a particular element (which in our case is ln(x, y)) within the
given input. Besides, the proposed MTL framework offers several advantages over
single task learning models [142, 146, 147]: first, it overcomes the risk of overfitting
by increasing the discriminative ability of shared weights. Second, the inference time
for the MTL framework is relatively less as it involves single (forward) propagation
for handling multiple tasks.
5.3.2 Survival Analysis
For survival analysis, we selected one of the DLBCL cohorts as discovery and the
other one as the validation cohort. The discovery cohort contains 32 DLBCL samples
included 10 from female patients and 22 from male patients. 11 had been categorised
as germinal centre B-cell (GCB) type, 20 as activated B-cell (ABC) type and one was
uncategorised. The age range of the patients was 24 to 90 years, with an average age
of 63.6 years. There were 7 stage 1, 10 stage 2, 8 stage 3 and 7 stage 4 tumours. The
average follow-up period was 1335 days, and 20 of the 32 patients died. The GT for
cell detection and classification was also collected from this cohort. The validation
cohort contains 27 DLBCL samples included 9 from female patients and 18 from
male patients. Tow cases were later excluded from the analysis due to overstaining
and overall quality of the scanned images. Out of those 27, 11 had been categorised
as GC-type, and 16 as ABC-type. The age range of the patients was 30 to 86 years,
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Figure 5.9: The Hydra-Net confusion matrices for two different patch sizes (a) 51×51
and (b) 61× 61 for all the three classes of cell classification.
with an average age of 67.2 years. There were 8 stage 1, 2 stage 2, 6 stage 3 and
11 stage 4 tumours. The average follow-up period was 1130 days, and 14 of the 27
patients died.
To obtain the DPS for each WSI, we aggregate the DPSs obtained from
image tiles. The qualitative results along with DPS for WSI results are shown
in Figure 5.8. We observed that a large part of the tissue region contains very
weak association (mainly due to normal regions) between tumour cells and collagen.
Therefore, to avoid the over-localisation of very weak associations, we only report
survival analysis on the remaining 3 categories excluding the very weak associations
(which we named as DPS-3). It is worth mentioning that we separately perform sum
to unity scaling on the statistics from DPS-3. To evaluate the prognostic signifi-
cance, for each DPS category, a Kaplan-Meier (KM) and Cox proportional-hazards
analysis were performed. The patients were stratified into two groups based on the
optimal cut-off of the DPS proportion selected from the discovery cohort. The op-
timal cut-off on each DPS category was selected where the statistical significance
between the two groups is the largest. We report the hazard ratio along with lower
and upper 95% confidence interval. Statistical significance of each KM analysis was
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Table 5.2: Contains DPS-3 p-values from overall survival (OS) analysis on validation
and discovery cohorts.
Validation cohort
p-value hazard ratio CI Lower 95% CI Upper 95% OS worse in
weak 0.28 2.3 0.49 11 High
moderate 0.0798 0.32 0.084 1.2 Low
strong 0.0356 0.3 0.095 0.98 Low
Discovery cohort
p-value hazard ratio CI Lower 95% CI Upper 95% OS worse in
weak 0.0031 15 1.4 170 High
moderate 0.0032 0.067 0.006 0.74 Low
strong 0.0241 0.37 0.15 0.91 Low
quantified using the log-rank test. For DPS-4, the univariate analysis revealed a
non-significant trend for different associations of tumour-collagen regions with the
inferior OS. The results obtained for DPS-3 are shown in Figure 5.10 and p-values of
0.0031, 0.0032, 0.0241 were obtained on the discovery cohort and 0.28, 0.0798, 0.0356
on the validation cohort for weak, moderate, and strongly associated regions, re-
spectively. Moderate and strongly associated regions showed the opposite trend as
compared to the weak association. This might be explained by the fact that weak
associations are negatively correlated with the other DPS-3 proportions. Table 5.2
gives all p-values for DPS associations with survival. Our DPS-3 image biomarker
suggests that patients whose tumours exhibit strong tumour-collagen associations
appear to experience superior OS.
5.4 Discussion
Collagen is regarded as the most abundant protein and one of the core macro-
molecules in the extracellular matrix [148]. The extracellular matrix is a primary
component of tumour-stroma and responsible for providing structural support to
keep different tissues and cells connected. During tumour progression, along with
malignant cells, stromal regions experience structural variations which include col-
lagen degradation, and remodelling [149]. Conventionally, the role of collagen is
to resist tumour proliferation whereas there are some studies that have reported
the abundance of collagen expression may initiate and promote tumour progression
[150]. It is also evident from a number of studies that collagen may acts as a double-
edged sword in tumour progression [151]. However, the role of collagen expression
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Figure 5.10: Kaplan-Meier survival curves from DPS-3 for strongly associated
tumour-collagen regions of discovery (top) and validation cohorts (bottom). The
horizontal axis shows the time in months and the vertical axis represents the prob-
ability of overall survival.
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varies with different types of cancer and their stages. For instance, Mattix et al.
[152] analysed the quantity of collagen for brain and prostate tumour cases. They
observed the quantity of collagen increases with an increase in tumour proliferation
for brain tissue. For prostate cancer patients, the opposite trend was observed,
for earlier stages, there was an abundance of collagen content as compared to the
advanced stages of the tumour where a decrease in collagen content was recorded.
More recently, another study performed on DLBCL cases of mouse model shows
an increased amount of collagen was observed for earlier stages of lymphoma as
compared to later stages [153].
The adoption of computational pathology in routine clinical practice has
increased the importance of imaging based biomarkers for predicting patients out-
come. The proposed framework may serve as an independent prognostic marker to
predict survival in DLBCL patients and may overcome subjectivity and pathologists
workload. It can be observed from the experimental results (Table 5.2) that p-value
for the strong association is largely comparable for validation and discovery cohorts.
Data clustering is an active area of research and has several applications in a variety
of domains like data science and computer vision. Our intent here is to select a
simple yet effective clustering approach like k-means. It is worth mentioning that in
most of the implementations (among different variants of k-means), the time com-
plexity (TC) of k-means grows linearly O(n) as opposed to most of the hierarchical
clustering methods where their TC grows O(n2). One limitation of this work is the
selection of parameters like k (in k-means), which are empirically selected for this
study and may need appropriate readjustments, depending upon the requirements
and datasets. Our main intent of selecting k = 4 is to relate the estimated DPS
with clinician’s practice as we have seen in the previous chapter where pathologist
normally score HER2 cases into four categories (0−3+). An interesting extension of
this work would be to estimate proximity between tumour and collagen regions us-
ing graph-theories or graph CNN. However, such models would require a large scale
of annotated regions representing different types of tumour-collagen associations to
effectively train the selected graph CNN.
There are 28 known distinct types of collagen and overall they cover one-third
of whole body protein [154] and around 90% of bone protein. In this study, we have
investigated collagen VI in diffuse large B-cell lymphoma which normally contributes
to the formation of muscle, bone, cornea, dermis, and cartilage. Our results show
that strong proximity of collagen and tumour cells is linked to better OS in DLBCL
patients (discovery cohort: p-value=0.0241, validation cohort: p-value=0.0356). Un-
doubtedly, in survival analysis, the plausibility of statistical findings increases with
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an increased number of patients involved in that study. However, to some extent,
one major factor that influences the cohort size is the incidence rate of a partic-
ular disease. DLBCL is a type of non-Hodgkin lymphomas and their occurrence
in combined UK and USA are reported to be 7 to 8 patients from 100,000 people
[155]. The significance of the proposed DPS is not only limited to survival analysis.
DLBCL is regarded as a heterogeneous malignancy and behaves differently from pa-
tient to patient. The DPS also highlights the inter- and intra-tumour heterogeneity
within different DLBCL tumours, which might reflect its biological heterogeneity
and merit further clinicopathological investigation. Lastly, the proposed model is
the first study of its kind that performs automated analysis in exploring prognostic
biomarkers for predicting OS in DLBCL patients and it offers an interesting prospect
for upcoming studies with a large cohort from multiple centres.
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Chapter 6
Conclusions and Future Work
This chapter provides a concise summary of the presented work. We also discuss
some of the future directions for further exploration of the concepts and algorithms
presented in this thesis.
In this thesis, we presented a range of automated methods for quantitative
assessment of cancerous WSIs, to address some of the ongoing challenges in com-
putational pathology. The developed algorithms cover both H&E and IHC stained
histology WSIs and include (a) the employment of persistent homology and deep
CNNs for tumour segmentation of CRC, (b) a systematic study to evaluate the
performance of automated algorithms for HER2 scoring in BC patients, (c) a DRL
based attention mechanism that enables the model to learns where to see, (d) a
blend of deep learning and digital image processing based approaches to compute
summary level statistics from a WSI which may serve as a potential biomarker for
predicting OS in DLBCL patients.
The ultimate destination of a computational pathology algorithm is to be-
come a part of routine clinical practice. This work has the potential to assist in
building computer-assisted diagnostic tools. There are 3 main aspects which need
to be considered before the deployment of automated tools. First, the integra-
tion of effective pre-processing approaches which adequately handle the artefacts
generally occurring during slide preparation and digitisation. These artefacts may
misspend precious computational time and influence model performance without
any significant performance gain. Second, an extensive large-scale validation would
be required on multi-centric datasets, prepared with a variety of slide preparation
standards and scanners from different vendors. Third, the incorporation of interac-
tive machine learning (IML) mechanism [156] which enables effective retraining and
reduction in classification errors with the help of expert pathologists is needed.
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6.1 Tumour Segmentation
In Chapter 2, we have shown an application of persistent homology (based on alge-
braic topology) in distinguishing cancerous regions from their normal counterparts.
It also emphasises developing fast and accurate tumour segmentation algorithms for
analysing large-scale histology images. In this work, we have restricted ourselves to
deep convolutional networks which are better understood for images. An interesting
direction could be to treat the homology profiles as a one dimensional (1D) signal.
There could be several options to explore such temporal data and one of
the most well-known approaches is to employ the recurrent models. Unlike con-
ventional models, RNNs build the temporal connections between different inputs
tN = (t0, t1, ...., tn) and pass the relevant contextual information to the proceeding
inputs. One straightforward approach can be seen in Figure 6.1. It is worth men-
tioning that RNNs (especially vanilla RNNs) generally struggle with long-term data
dependencies. To overcome the problem of vanishing gradients, LSTM was intro-
duced with input, output and a forget gate. Depending on the requirements, such
a setting would require a careful selection of threshold range to avoid the shrinking
of the gradient in earlier layers of the LSTM.
6.2 HER2 Scoring Contest
Accessing high-quality medical imaging datasets has always been a challenge for
computer science researchers. On the other hand, validation and evaluation of novel
automated methods on state-of-the-art datasets is crucial for attaining generalisabil-
ity. We believe that HER2 Scoring Contest has provided a baseline for researchers in
computational pathology community for comparing their automated/semi-automated
scoring methods and contribute towards advancing the automated analysis of IHC
stained WSIs.
A potential extension to appropriately tackle the borderline (2+) cases of
HER2 scoring is by incorporating FISH dataset. All cases with score 2+ are rou-
tinely recommended for further FISH testing to validate HER2 over-expression at
the gene level. It would be an added advantage if the automated methods could be
trained with FISH GT to predict the final outcome and the potential for automated
algorithms in calling the actual final HER2 status with reproducible accuracy could
be demonstrated. For this, a larger series with 2+ cases along with FISH data
would need to be tested. Indeed, there have been promising studies that indicate
that automated image analysis for HER2 instead of manual assessment may reduce
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Figure 6.1: An illustration of using recurrent neural networks for handling homology
profiles. (a) Independently compute the β0, and β1 (b) concatenate the feature
representation of β0, β1 (c) feed the combined feature representation to a recurrent
model.
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the need for supplementary FISH testing by up to 68% [157]. In a diagnostic set-
ting, this would significantly reduce costs and turn-around time. During the last
decade, IHC staining has become ubiquitous in pathology labs around the world
and the role of IHC evaluation in a high-throughput setting becomes key for IHC
based companion diagnostics. Other possible extensions of digital pathology could
be to automate the over-expression of the programmed death 1 (PD-1) receptor
and its ligand (PD-L1), to evaluate anaplastic lymphoma kinase (ALK) protein and
proto-oncogene tyrosine-protein kinase ROS1 in lung cancers [158]. The AI based
algorithms would be more effective if IHC staining and scoring methods were treated
as a composite assay [158, 159, 160]. The varying staining protocols and scoring pa-
rameters may restrain the effectiveness of AI based automated scoring algorithms
including the HER2 scoring but with sufficiently variable data from different centres,
AI algorithms could be trained to overcome that problem.
6.3 Learning Where to See
Reinforcement learning has greatly contributed to the development of self-driving
autonomous cars and industrial automation. In fact, nowadays, DRL based algo-
rithms are serving as the backbone for academic and industrial research on au-
tonomous cars and robotics [161, 162]. This kind of learning enables the model to
sequentially interact with its environment and respond with suitable line of actions
to maximise the reward function. The usability and scope of DRL have been not
fully explored in the domain of computational pathology. We proposed a DRL based
attention mechanism that demonstrates the usability of DRL for automated IHC
scoring.
One possible extension of our work to achieve end-to-end learning would be
to devise a multi-stage (or multi-scale) attention mechanism. This can be achieved
by formulating multi-stage cascaded models. In the first stage, the model would
analyse the given WSI at a lower magnification (1.25× or lower) to identify the
potential ROIs and in the second stage the attention model would analyse selected
ROIs at higher resolutions (40×, 20×) to learn the discriminative features. However,
such a model would require a prudent selection of reward function(s) and tuning
of hyper-parameters to ensure the inclusion of diagnostically relevant regions in
the first stage. In addition, the model would require a large number of WSIs to
effectively optimise the weights for the first stage of the attention model.
114
6.4 Tumour-Collagen Proximity Analytics
In chapter 5, we have described a tumour-collagen proximity signature that can
predict overall survival in DLBCL. We proposed the computing of the DPS by first
detecting and classifying tumour cells using a multi-headed Hydra-Net. Second, we
performed tumour-collagen proximity analysis by aggregating tumour cell statistics
within the vicinity of collagen regions. DLBCL is a heterogeneous malignancy and
tumour progression may vary among different patients. We have provided a baseline
to highlight the inter- and intra-tumour heterogeneity, which may be helpful in
better understanding of disease progression. One potential extension of this work
could be to explore the collagen patterns and investigate why these patterns vary
from case to case. Does it have any underlying molecular basis? Is it a cause
or consequence of tumour behaviour? These findings are compelling observations
which merit further clinicopathological investigations on larger patient cohorts.
6.5 Concluding Remarks
In this thesis, we have presented automated algorithms for quantitative assessment
of cancerous whole slide images. The presented work provides a platform for further
investigation on the role of algebraic topology and attention based reinforcement
learning models. The presented studies demonstrate that machine learning based
automated algorithms can be effectively used in the area of computational pathology.
The journey towards developing computer-assisted diagnostic systems requires sub-
stantial resources for conducting large-scale clinical validation of automated methods
for assisting experts in fighting one of the deadliest diseases of the current era.
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Appendix A
The Proposed Algorithms in the
HER2 Scoring Contest
The work presented in this appendix contains the description of the presented algo-
rithms in the HER2 scoring contest.
A.1 Related Work
Automated image analysis is regarded as a solution [29, 163] to overcome the inter-
and intra- observer variations found in the conventional assessment of tissue slides.
In literature, a wide range of handcrafted features was proposed for IHC scoring
algorithms [108, 164].
For instance, Choudhury et al. [165] proposed an averaged threshold measure
(ATM) for scoring of digitised images of IHC stained tissue microarrays. A set of
arbitrarily chosen thresholds were selected, whereby an optimal threshold using the
ATM is used for calculating the percentage of the stained area. The proposed ATM
statistic presented as a generalisation of the HSCORE [166] statistic for scoring IHC
slides. Reyes-Aldasoro et al. [167] presented an alternative approach for automated
segmentation of microvessels in IHC tumour slides. For segmentation, distinguish-
ing hues of stained vascular endothelial nuclei and tissue regions were explored to
extract the seeds for a region-growing model. Their post-processing of segmented
microvessels from CD31 immunostaining contained three steps, closing morpholog-
ical objects from tumour margins, combining isolated objects, and splitting objects
into individual vessels with having multiple lumen. Although the thresholding ap-
proaches perform well on a specific dataset, they are likely to fare not as well on an
unseen dataset as distinctive hues can be significantly varying. A potential reason
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for such variation lies in the staining process, as the histology slides normally stained
at different occasions with inconsistent concentrations often exhibit large variations
in colour and appearance. Such differences in slide preparation make the colour and
morphological appearance of tissue components more unpredictable.
Kuse et al. [168] used local isotropic phase symmetry measure as a significant
feature for beta cell detection and lymphocytes. By calculating the peak of median
phase energy after stain normalisation but due to heterogeneous appearance and
often-clumped structure makes nuclei segmentation a non-trivial task. Khan et
al. [108] used stain quantisation for the scoring of the Estrogen Receptor (ER)
and Progesterone Receptor (PR) by determining the amount of chromatin material
and protein content from IHC stained WSIs. Ali et al. [169] used astronomical
algorithms for the scoring of ER on IHC stained images of breast cancer. However,
in this contest, the classical machine learning approaches have been outperformed by
deep learning approaches. Most of the published algorithms are based on different
approaches with different dataset whereas this contest provides a platform where
participants can develop and validate the performance of their algorithms on the
same dataset.
A.2 Description of the Proposed Automated Methods
This section provides a concise description of automated methods employed by some
of the top-ranked teams.
A.2.1 VISILAB
In this method, a state-of-the-art GoogLeNet [99] was implanted to predict the
HER2 score and the percentage of the complete cell membrane.
Data Preparation: A set of representative patches of the four HER2 scoring
classes were extracted from the ground truth WSIs. Additionally, an extra class
was employed to collect background samples. These extracted patches from train-
ing WSIs were 68 × 68 pixels size each. A total of 5750 patches were selected with
an average of 1150 patches per class. The dataset was further split into training
(75%) and validation (25%) dataset.
Training: Among several state-of-art CNNs, GoogLeNet was finally selected for
submission according to the results on the validation dataset. The prepared dataset
was used for training, by selecting 0.01 as the base learning rate, with a decreasing
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policy over 50 epochs, using the Stochastic Gradient Descent.
Classification: The algorithm takes a WSI and applies a grid technique to ob-
tain the corresponding patches, with a similar size than the ones from the training
dataset. These are later classified with the trained model, whose output is a class
prediction and a percentage of confidence over that decision.
HER2 Scoring: Once every single patch is classified, a single class score is pro-
vided for the WSI. The decision rule takes into account the percentage of patches
that belong to each class (omitting the background, which was treated as a separate
class) using the following criteria: starting from class 3+ to class 1+, the first one
to achieve at least 10% of patches is chosen as the final decision. Regarding the per-
centage of cells with full membrane staining, a customised expert rule was developed
by calculating the staining density for different nuclei. As a result, a relationship
between the classes percentage distribution and the percentage of membrane cell
staining was discovered.
A.2.2 FSUJena
The algorithm for the automated HER2 scoring was based on Alexnet [52] CNN. In
this method, an activation matrix was extracted after convolution layers to compute
the bilinear filters.
At the first, ROIs were manually probed and patches of size 227 × 227 were
randomly extracted at 20×. The pre-trained version of Alexnet was used from Ima-
geNet dataset for further training on contest dataset. For each patch in the training
dataset, an activation matrix was extracted after convolutional layers. The activa-
tions can be represented as a tensor x ∈ Rw×h×d comprised of d-dimensional vectors
in a w×h spatial grid. The bilinear features [170, 171] were further computed as the





i,j . The matrix G contains the second-order statistics of the CNN
features and have been found to be extremely useful for fine-grained recognition
tasks. Then the square root and L2 normalisation of G were employed to increase
the numerical stability of further processing steps [171].
To differentiate among four scoring classes a multi-class logistic regression
was used. It was also observed that using a pre-trained network on ImageNet dataset
is also beneficial to avoid the overfitting issues. In preliminary results, the bilinear
features approach outperformed the conventional CNN activations. During the test,
an average was calculated for all the randomly cropped patches. To predict the
118
PCMS the mean tumour cell percentage seen in the training set of for a particular
class as an estimate.
A.2.3 Huangch
In this approach, a range of handcrafted features extracted from the IHC stained
slides after performing the stain deconvolution. The handcrafted features were then
fed into a model of multi-class AdaBoost decision trees.
Pre-processing: Control tissues were extracted to developed a pseudo colour space
for stain deconvolution [127] to obtain the two staining vectors. Further, mean fil-
tering was performed to record the local maximal points. The patches were selected
from each WSI on the basis of local maximal points as they were representing the
strongest HER2 stained overexpression signals
Feature Extraction and Classification: A combined but numerically inde-
pendent features vector space constructed by including Gabor Filtering, Features
of Fractal Dimension by Differential Box-Counting, multi-wavelet methods, his-
togram statics methods, and grey-level (over all colour channels) co-occurrence based
method [172, 173] etc.
For predicting the HER2 score and the PCMS, a model of multi-class Ad-
aBoost decision-trees was employed to map the features vector of each patch to
a predicted value. This model is known as Stagewise Additive Modelling using a
Multi-class Exponential [174] loss function (SAMME). The model composed by a
series of decision-trees by assigning a weight to each decision-tree. Whereas while
training, a pool of decision-trees were generated and after each iteration the best
decision-tree was selected with its corresponding weight. After certain iterations, a
group of decision-trees were selected for the testing phase.
A.2.4 Team Indus
In this approach, a deep CNN was employed for predicting the HER2 score whereas
for estimating the PCMS, a set of handcrafted morphological features were extracted
from H&E and IHC stained slides.
Pre-processing: Patches with an average strength (intensity) lies higher then a
certain threshold were selected for training the CNN.
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HER2 Score Prediction: The presented CNN architecture contains five convo-
lutional layers, one concatenation layer with following two fully connected and one
classification layer. After each convolution and fully connected layer, a ReLu activa-
tion was performed whereas for classification layer a softmax activation was placed.
After convolution layers, a concatenation layer was also positioned. The concatena-
tion layer combines the activation maps from the convolution layers and the average
control tissue intensity for the corresponding WSI from which the patches were
originated. The weights for training CNN were updated using mini batch gradient
descent (learning rate = 0.00015, weight decay = 106, Nesterov momentum = 0.95,
batch size = 32). The CNN was trained over 41K patches generated each of size
224x224 from 52 training WSIs for 65 epochs. During testing, the trained network
assigned a score to each patch of a WSI and to aggregate the patch scores into a
single HER2 score following criteria was proposed. Let n0, n1, n2 and n3 be the
number of patches scored as 0, 1+, 2+ and 3+ respectively and N be the total
number of patches generated from a WSI.
PCMS Estimation: To estimate the PCMS, first tumour regions were identi-
fied by extracting the morphological features from tumour and normal regions of
H&E images. After that stain normalisation [127] was performed by selecting the
haematoxylin channel to segment the nuclei using Otsu thresholding. Further, nu-
clei contours were fit around each individual structure and filtered on the basis of
area and eccentricity. This resulted in tumour identification regions by detecting
tumour nuclei based on their roundness and size. In order to estimate the extent of
membrane staining, the morphological features were extracted from an IHC image.
In addition, a contagious chicken-wire pattern was observed for complete membrane
stained regions whereas other tissue components result in a fragmented/broken-up
skeleton. Further, by filling holes in the chicken-wire skeleton and by measuring
similarity with the original binary image the extent of membrane staining was es-
timated. The PCMS is estimated by calculating the ratio between the extent of
membrane staining and tumour identification regions.
A.2.5 MUCS
In this submission, the well-known neural networks Alexnet [52] and GoogLeNet [99]
were adapted by adjusting the layer specific parameters, such as kernel size, stride,
and padding. There were three submissions from the MUCS team with two submis-
sions using Alexnet (MUCS-1 and MUCS-2) and one using GoogLeNet (MUCS-3).
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Model Training: The training dataset was obtained by hand-picking the regions
of interest from 52 training IHC images that were considered to contain the most
representative samples from each class. The regions were selected from the low
resolution (0.625×) and mapped to the highest resolution (40×) whereupon each
region was divided into 128 × 128 pixel patches. The MUCS-1 trained network had
four output classes with corresponding HER2 scores from 0 to 3+. MUCS-2 and
MUCS-3 had an additional output class for the background. The background class
contained the regions with a texture having only a weak appearance of nuclei (with-
out blueish or brownish colour). The training dataset for MUCS-2 was extended by
data augmentation (rotation and mirroring) and by adding the hand-picked regions
from test images (without knowing the classification of the slide it originated from).
The total patches for MUCS-1, MUCS-2 and MUCS-3 were 29,000, 31,9000 and
33,500, respectively. The training images were divided between actual training data
(75%) and validation data (25%). For all three submissions, the base learning rate
was set to 0.001, and the learning rate was dropped every one-third of the maximum
iterations by a factor of 10 (γ = 0.1). The mean pixel value was subtracted from
the training dataset.
Model Inference: For testing, the common regions from H&E and IHC were
selected at a low resolution and those regions were mapped to maximum resolution
to generate the patches for testing. Further, adaptive thresholding was applied to
each patch, with an offset of 10, to produce a binary image. If the proportion of ones
in the binary image was smaller than a factor of 0.9, then patch was classified with
the trained model, otherwise, the patch was marked as background and therefore
did not require classification. The HER2 score for a WSI was determined using the
classified patches as follows:
• Score 3+, if patches with class 3+ was greater than or equal to 10% of total
patches
• Score 2+, if patches with class 2+ was greater than or equal to 10%, or patches
with class 3+ was between 1% and 10%, of total patches
• Score 1+, if patches with class 1+ was greater than or equal to 10% of total
patches
• Score 0, otherwise
The confidence value for each WSI was calculated by averaging the confidence
values of each patch. PCMS was calculated by summing the number of score 3+
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and 2+ patches and dividing the sum by total number of patches (excluding the
background) as given below






where n is the number of patches given score s, s ∈ {0, 1, 2, 3}.
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Feeley, Miles R Holbrook, Robert J Landers, Phillip B Lumb, and Timothy J
Stephenson. What levels of agreement can be expected between histopathol-
ogists assigning cases to discrete nominal categories? a study of the diagnosis
of hyperplastic and adenomatous colorectal polyps. Modern Pathology, 13(9):
941, 2000.
[32] Babak Ehteshami Bejnordi, Mitko Veta, Paul Johannes van Diest, Bram
van Ginneken, Nico Karssemeijer, Geert Litjens, Jeroen AWM van der Laak,
Meyke Hermsen, Quirine F Manson, Maschenka Balkenhol, et al. Diagnostic
assessment of deep learning algorithms for detection of lymph node metastases
in women with breast cancer. Jama, 318(22):2199–2210, 2017.
[33] Siyamalan Manivannan, Wenqi Li, Jianguo Zhang, Emanuele Trucco, and
Stephen J McKenna. Structure prediction for gland segmentation with hand-
crafted and deep convolutional features. IEEE transactions on medical imag-
ing, 37(1):210–221, 2018.
[34] Emad A Rakha, Sarah E Pinder, John MS Bartlett, Merdol Ibrahim, Jane
Starczynski, Pauline J Carder, Elena Provenzano, Andrew Hanby, Sally Hales,
Andrew HS Lee, et al. Updated uk recommendations for her2 assessment in
breast cancer. Journal of clinical pathology, 68(2):93–99, 2015.
[35] Lee AD Cooper, Alexis B Carter, Alton B Farris, Fusheng Wang, Jun Kong,
David A Gutman, Patrick Widener, Tony C Pan, Sharath R Cholleti, Ashish
Sharma, et al. Digital pathology: Data-intensive frontier in medical imaging.
Proceedings of the IEEE, 100(4):991–1003, 2012.
126
[36] Adam Goode, Benjamin Gilbert, Jan Harkes, Drazen Jukic, and Mahadev
Satyanarayanan. Openslide: A vendor-neutral software foundation for digital
pathology. Journal of pathology informatics, 4, 2013.
[37] David Taubman and Michael Marcellin. JPEG2000 image compression funda-
mentals, standards and practice: image compression fundamentals, standards
and practice, volume 642. Springer Science & Business Media, 2012.
[38] David N Louis, Georg K Gerber, Jason M Baron, Lyn Bry, Anand S Dighe,
Gad Getz, John M Higgins, Frank C Kuo, William J Lane, James S Michael-
son, et al. Computational pathology: an emerging definition. Archives of
pathology & laboratory medicine, 138(9):1133–1138, 2014.
[39] Philip D Dunne, Darragh G McArt, Conor A Bradley, Paul G O’Reilly, He-
len L Barrett, Robert Cummins, Tony O’Grady, Ken Arthur, Maurice B
Loughrey, Wendy L Allen, et al. Challenging the cancer molecular strati-
fication dogma: intratumoral heterogeneity undermines consensus molecular
subtypes and potential diagnostic value in colorectal cancer. Clinical Cancer
Research, 22(16):4095–4104, 2016.
[40] Geert Litjens, Clara I Sánchez, Nadya Timofeeva, Meyke Hermsen, Iris Nagte-
gaal, Iringo Kovacs, Christina Hulsbergen-Van De Kaa, Peter Bult, Bram
Van Ginneken, and Jeroen Van Der Laak. Deep learning as a tool for in-
creased accuracy and efficiency of histopathological diagnosis. Scientific re-
ports, 6:26286, 2016.
[41] Talha Qaiser, Abhik Mukherjee, Chaitanya Reddy PB, Sai D Munugoti,
Vamsi Tallam, Tomi Pitkaho, Taina Lehtimki, Thomas Naughton, Matt
Berseth, Anbal Pedraza, Ramakrishnan Mukundan, Matthew Smith, Abhir
Bhalerao, Erik Rodner, Marcel Simon, Joachim Denzler, Chao-Hui Huang,
Gloria Bueno, David Snead, Ian O Ellis, Mohammad Ilyas, and Nasir Ra-
jpoot. Her2 challenge contest: a detailed assessment of automated her2 scor-
ing algorithms in whole slide images of breast cancer tissues. Histopathol-
ogy, 72(2):227–238, 2018. ISSN 1365-2559. doi: 10.1111/his.13333. URL
http://dx.doi.org/10.1111/his.13333.
[42] Alecsandru Ioan Baba and Cornel Câtoi. Comparative oncology. Publishing
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Identification of tumor epithelium and stroma in tissue microarrays using tex-
ture analysis. Diagnostic pathology, 7(1):22, 2012.
[46] Dogan Altunbay, Celal Cigir, Cenk Sokmensuer, and Cigdem Gunduz-Demir.
Color graphs for automated cancer diagnosis and grading. IEEE Transactions
on Biomedical Engineering, 57(3):665–674, 2010.
[47] Adnan M Khan, Hesham El-Daly, Emma Simmons, and Nasir M Rajpoot.
Hymap: A hybrid magnitude-phase approach to unsupervised segmentation
of tumor areas in breast cancer histology images. Journal of pathology infor-
matics, 4(Suppl), 2013.
[48] Jakob Nikolas Kather, Cleo-Aron Weis, Francesco Bianconi, Susanne M
Melchers, Lothar R Schad, Timo Gaiser, Alexander Marx, and Frank Gerrit
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[160] Marius Ilie, Véronique Hofman, Manfred Dietel, Jean-Charles Soria, and Paul
Hofman. Assessment of the pd-l1 status by immunohistochemistry: challenges
and perspectives for therapeutic strategies in lung cancer patients. Virchows
Archiv, 468(5):511–525, 2016.
[161] Jens Kober, J Andrew Bagnell, and Jan Peters. Reinforcement learning in
robotics: A survey. The International Journal of Robotics Research, 32(11):
1238–1274, 2013.
[162] Shai Shalev-Shwartz, Shaked Shammah, and Amnon Shashua. Safe, multi-
agent, reinforcement learning for autonomous driving. arXiv preprint
arXiv:1610.03295, 2016.
[163] JD Webster and RW Dunstan. Whole-slide imaging and automated image
analysis: considerations and opportunities in the practice of pathology. Vet-
erinary pathology, 51(1):211–223, 2014.
[164] Shazia Akbar, Lee B Jordan, Colin A Purdie, Alastair M Thompson,
and Stephen J McKenna. Comparing computer-generated and pathologist-
generated tumour segmentations for immunohistochemical scoring of breast
tissue microarrays. British journal of cancer, 113(7):1075, 2015.
[165] Kingshuk Roy Choudhury, Kevin J Yagle, Paul E Swanson, Kenneth A Krohn,
and Joseph G Rajendran. A robust automated measure of average antibody
staining in immunohistochemistry images. Journal of Histochemistry & Cyto-
chemistry, 58(2):95–107, 2010.
[166] Yutaka Hatanaka, Kaoru Hashizume, Kazuo Nitta, Tomoyuki Kato, Ichiro
Itoh, and Yoichi Tani. Cytometrical image analysis for immunohistochemical
hormone receptor status in breast carcinomas. Pathology international, 53
(10):693–699, 2003.
[167] Constantino Carlos Reyes-Aldasoro, Leigh J Williams, Simon Akerman,
Chryso Kanthou, and Gillian M Tozer. An automatic algorithm for the seg-
mentation and morphological analysis of microvessels in immunostained his-
tological tumour sections. Journal of Microscopy, 242(3):262–278, 2011.
140
[168] Manohar Kuse, Yi-Fang Wang, Vinay Kalasannavar, Michael Khan, and Nasir
Rajpoot. Local isotropic phase symmetry measure for detection of beta cells
and lymphocytes. Journal of pathology informatics, 2, 2011.
[169] Hamid Raza Ali, M Irwin, L Morris, SJ Dawson, FM Blows, E Provenzano,
B Mahler-Araujo, PD Pharoah, NA Walton, JD Brenton, et al. Astronomical
algorithms for automated analysis of tissue protein expression in breast cancer.
British journal of cancer, 108(3):602, 2013.
[170] Yang Gao, Oscar Beijbom, Ning Zhang, and Trevor Darrell. Compact bilinear
pooling. In Proceedings of the IEEE conference on computer vision and pattern
recognition, pages 317–326, 2016.
[171] Tsung-Yu Lin, Aruni RoyChowdhury, and Subhransu Maji. Bilinear cnn mod-
els for fine-grained visual recognition. In Proceedings of the IEEE international
conference on computer vision, pages 1449–1457, 2015.
[172] Po-Whei Huang and Cheng-Hsiung Lee. Automatic classification for patholog-
ical prostate images based on fractal analysis. IEEE transactions on medical
imaging, 28(7):1037–1050, 2009.
[173] Matthew D DiFranco, Gillian OHurley, Elaine W Kay, R William G Watson,
and Padraig Cunningham. Ensemble based system for whole-slide prostate
cancer probability mapping using color texture features. Computerized medical
imaging and graphics, 35(7-8):629–645, 2011.
[174] Trevor Hastie, Saharon Rosset, Ji Zhu, and Hui Zou. Multi-class adaboost.
Statistics and its Interface, 2(3):349–360, 2009.
141
